Attached files
file | filename |
---|---|
EX-31.1 - EX-31.1 - IXYS, LLC | f54828exv31w1.htm |
EX-10.1 - EX-10.1 - IXYS, LLC | f54828exv10w1.htm |
EX-31.2 - EX-31.2 - IXYS, LLC | f54828exv31w2.htm |
EX-32.1 - EX-32.1 - IXYS, LLC | f54828exv32w1.htm |
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
(Mark One)
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended December 31, 2009
or
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
COMMISSION FILE NUMBER 000-26124
IXYS CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE | 77-0140882 | |
(State or other jurisdiction | (I.R.S. Employer Identification No.) | |
of incorporation or organization) |
1590 BUCKEYE DRIVE
MILPITAS, CALIFORNIA 95035-7418
(Address of principal executive offices and Zip Code)
MILPITAS, CALIFORNIA 95035-7418
(Address of principal executive offices and Zip Code)
(408) 457-9000
(Registrants telephone number, including area code)
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its
corporate Web site, if any, every
Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T
(§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
Yes o No o
Indicate by check mark whether the
registrant is a large accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of large accelerated
filer, accelerated filer and smaller reporting company in Rule 12b-2 of the
Exchange Act. (Check one):
Large accelerated filer o | Accelerated filer þ | Non-accelerated filer o | Smaller reporting company o | |||
(Do not check if a smaller reporting company) |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes o No þ
The number of shares of the registrants common stock, $0.01 par value, outstanding as of January
29, 2010 was 31,329,514.
IXYS CORPORATION
FORM 10-Q
December 31, 2009
December 31, 2009
INDEX
2
Table of Contents
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
December 31, | March 31, | |||||||
2009 | 2009 | |||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 86,496 | $ | 55,441 | ||||
Restricted cash |
199 | 136 | ||||||
Accounts receivable, net of allowances of $1,579 at December 31, 2009 and
$1,899 at March 31, 2009 |
36,542 | 37,251 | ||||||
Inventories |
65,378 | 75,601 | ||||||
Prepaid expenses and other current assets |
4,791 | 3,994 | ||||||
Deferred income taxes |
13,017 | 12,797 | ||||||
Total current assets |
206,423 | 185,220 | ||||||
Property, plant and equipment |
47,691 | 52,912 | ||||||
Other assets |
9,602 | 6,728 | ||||||
Deferred income taxes |
8,106 | 7,972 | ||||||
Total assets |
$ | 271,822 | $ | 252,832 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Current portion of capitalized lease obligations |
$ | 3,450 | $ | 3,739 | ||||
Current portion of loans payable |
1,498 | 1,455 | ||||||
Accounts payable |
16,688 | 13,767 | ||||||
Accrued expenses and other current liabilities |
13,689 | 15,342 | ||||||
Total current liabilities |
35,325 | 34,303 | ||||||
Long term income tax payable |
4,845 | 4,845 | ||||||
Capitalized lease obligations, net of current portion |
2,322 | 4,418 | ||||||
Long term loans, net of current portion |
32,288 | 17,599 | ||||||
Pension liabilities |
14,360 | 13,175 | ||||||
Total liabilities |
89,140 | 74,340 | ||||||
Commitments and contingencies (Note 16) |
||||||||
Stockholders equity: |
||||||||
Preferred stock, $0.01 par value: |
||||||||
Authorized: 5,000,000 shares; none issued and outstanding |
| | ||||||
Common stock, $0.01 par value: |
||||||||
Authorized: 80,000,000 shares; 36,720,901 issued and 31,259,914 outstanding at
December 31, 2009 and 36,054,936 issued and 30,633,949 outstanding at March 31, 2009 |
367 | 361 | ||||||
Additional paid-in capital |
181,014 | 177,551 | ||||||
Treasury stock, at cost: 5,460,987 common shares at December 31, 2009 and
5,420,987 common shares at March 31, 2009 |
(45,662 | ) | (45,374 | ) | ||||
Retained earnings |
39,285 | 43,984 | ||||||
Accumulated other comprehensive income |
7,678 | 1,970 | ||||||
Total stockholders equity |
182,682 | 178,492 | ||||||
Total liabilities and stockholders equity |
$ | 271,822 | $ | 252,832 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
Table of Contents
IXYS CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
Net revenues |
$ | 64,032 | $ | 58,337 | $ | 166,663 | $ | 215,308 | ||||||||
Cost of goods sold |
48,321 | 45,683 | 128,000 | 154,095 | ||||||||||||
Gross profit |
15,711 | 12,654 | 38,663 | 61,213 | ||||||||||||
Operating expenses: |
||||||||||||||||
Research, development and engineering |
5,144 | 4,733 | 14,202 | 15,558 | ||||||||||||
Selling, general and administrative |
8,817 | 9,209 | 25,183 | 30,701 | ||||||||||||
Restructuring charges |
32 | | 1,042 | | ||||||||||||
Impairment charges |
| 3,749 | | 3,749 | ||||||||||||
Total operating expenses |
13,993 | 17,691 | 40,427 | 50,008 | ||||||||||||
Operating income (loss) |
1,718 | (5,037 | ) | (1,764 | ) | 11,205 | ||||||||||
Other income (expense): |
||||||||||||||||
Interest income |
108 | 254 | 317 | 980 | ||||||||||||
Interest expense |
(426 | ) | (405 | ) | (1,203 | ) | (1,349 | ) | ||||||||
Other income (expense), net |
691 | (109 | ) | (1,702 | ) | 1,624 | ||||||||||
Income (loss) before income tax |
2,091 | (5,297 | ) | (4,352 | ) | 12,460 | ||||||||||
(Provision for) benefit from income tax |
(1,692 | ) | 1,315 | (347 | ) | (4,899 | ) | |||||||||
Net income (loss) |
$ | 399 | $ | (3,982 | ) | $ | (4,699 | ) | $ | 7,561 | ||||||
Net income (loss) per share |
||||||||||||||||
Basic |
$ | 0.01 | $ | (0.13 | ) | $ | (0.15 | ) | $ | 0.24 | ||||||
Diluted |
$ | 0.01 | $ | (0.13 | ) | $ | (0.15 | ) | $ | 0.23 | ||||||
Cash dividends per share |
| | | $ | 0.10 | |||||||||||
Weighted average shares used in per share calculation |
||||||||||||||||
Basic |
31,100 | 30,979 | 30,893 | 31,238 | ||||||||||||
Diluted |
31,269 | 30,979 | 30,893 | 32,236 | ||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
Table of Contents
Nine Months Ended | ||||||||
December 31, | ||||||||
2009 | 2008 | |||||||
Cash flows from operating activities: |
||||||||
Net income (loss) |
$ | (4,699 | ) | $ | 7,561 | |||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
||||||||
Depreciation and amortization |
9,130 | 9,783 | ||||||
Provision for receivable allowances |
2,873 | 4,568 | ||||||
Net change in inventory provision |
3,056 | 6,054 | ||||||
Foreign currency adjustments on intercompany amounts |
1,235 | (157 | ) | |||||
Goodwill impairment charge |
| 3,749 | ||||||
Stock-based compensation |
2,443 | 1,925 | ||||||
Loss (gain) on investments and disposal of fixed assets |
(157 | ) | 182 | |||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(685 | ) | 5,808 | |||||
Inventories |
10,006 | (18,969 | ) | |||||
Prepaid expenses and other current assets |
465 | (2,541 | ) | |||||
Other assets |
45 | 57 | ||||||
Accounts payable |
2,164 | (3,664 | ) | |||||
Accrued expenses and other liabilities |
(2,579 | ) | 3,199 | |||||
Pension liabilities |
(61 | ) | (388 | ) | ||||
Net cash provided by operating activities |
23,236 | 17,167 | ||||||
Cash flows from investing activities: |
||||||||
Change in restricted cash |
(63 | ) | 482 | |||||
Business combination, net of cash and cash equivalents acquired |
(2,625 | ) | (420 | ) | ||||
Purchases of investments |
(554 | ) | (1,083 | ) | ||||
Purchases of property and equipment |
(2,565 | ) | (7,792 | ) | ||||
Proceeds from sale of investments |
398 | 3,923 | ||||||
Net cash used in investing activities |
(5,409 | ) | (4,890 | ) | ||||
Cash flows from financing activities: |
||||||||
Principal payments on capital lease obligations |
(3,058 | ) | (3,580 | ) | ||||
Repayments of long term loans and notes payable |
(1,136 | ) | (1,823 | ) | ||||
Proceeds from line of credit |
15,000 | | ||||||
Proceeds from employee equity plans |
1,026 | 3,480 | ||||||
Purchase of treasury stock |
(288 | ) | (7,290 | ) | ||||
Payment of dividend to stockholders |
| (3,161 | ) | |||||
Net cash provided by (used in) financing activities |
11,544 | (12,374 | ) | |||||
Effect of exchange rate fluctuations on cash and cash equivalents |
1,684 | (2,513 | ) | |||||
Net increase (decrease) in cash and cash equivalents |
31,055 | (2,610 | ) | |||||
Cash and cash equivalents at beginning of period |
55,441 | 56,614 | ||||||
Cash and cash equivalents at end of period |
$ | 86,496 | $ | 54,004 | ||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
Table of Contents
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. Unaudited Condensed Consolidated Financial Statements
The accompanying interim unaudited condensed consolidated financial statements have been
prepared in accordance with the instructions to Form 10-Q and do not include all of the information
and footnotes required by accounting principles generally accepted in the United States of America
for complete financial statements. The unaudited condensed consolidated financial statements
include the accounts of IXYS Corporation and its wholly-owned subsidiaries. The preparation of
financial statements in conformity with accounting principles generally accepted in the United
States requires management to make estimates and judgments that affect the amounts reported in the
financial statements and accompanying notes. The accounting estimates that require managements
most difficult judgments include, but are not limited to, revenue reserves, inventory valuation,
accounting for income taxes, allocation of purchase price in business combinations and
restructuring costs. All significant intercompany transactions have been eliminated in
consolidation. All adjustments of a normal recurring nature that, in the opinion of management, are
necessary for a fair statement of the results for the interim periods have been made. The condensed
balance sheet as of March 31, 2009 has been derived from our audited balance sheet as of that date.
It is recommended that the interim financial statements be read in conjunction with our audited
consolidated financial statements and notes thereto for the fiscal year ended March 31, 2009
contained in our Annual Report on Form 10-K. Interim results are not necessarily indicative of the
operating results expected for later quarters or the full fiscal year.
We have evaluated subsequent events through the date that the financial statements were issued
on February 5, 2010.
2. Accounting Changes and Recent Accounting Pronouncements
On July 1, 2009, the Financial Accounting Standards Board, or FASB, officially launched the
FASB Accounting Standards CodificationTM, or Codification, which has become the single
official source of authoritative, nongovernmental U.S. Generally Accepted Accounting Principles, or
GAAP. The Codification, which is effective for interim and annual periods ending on or after
September 15, 2009, is organized into approximately 90 accounting topics. Going forward, U.S. GAAP
will no longer be issued in the form of an accounting standard, but as an update to the
applicable topic or subtopic within the Codification. As such, accounting guidance will be
classified as either authoritative or non-authoritative based on its inclusion in or exclusion
from the Codification. We adopted the Codification starting with the quarter ended September 30,
2009.
In the quarter ended June 30, 2009, we adopted the authoritative guidance issued by the FASB
on business combinations. The guidance generally requires an entity to recognize the assets
acquired, liabilities assumed, contingencies, and contingent consideration at their fair value on
the acquisition date. In circumstances where the acquisition-date fair value for a contingency
cannot be determined during the measurement period and it is concluded that it is probable that an
asset or liability exists as of the acquisition date and the amount can be reasonably estimated, a
contingency is recognized as of the acquisition date based on the estimated amount. It further
requires that acquisition-related costs be recognized separately from the acquisition and expensed
as incurred, restructuring costs generally be expensed in periods subsequent to the acquisition
date, and changes in accounting for deferred tax asset valuation allowances and acquired income tax
uncertainties after the measurement period impact income tax expense. In addition, acquired
in-process research and development is capitalized as an intangible asset and amortized over its
estimated useful life. The guidance is applicable to business combinations on a prospective basis,
and applied to the acquisition of assets from Leadis Technology Inc., or Leadis, in the quarter
ended September 30, 2009. See Note 3, Business Combination for further information regarding the
acquisition.
In the quarter ended June 30, 2009, we adopted the authoritative guidance issued by the FASB
on fair value measurement for nonfinancial assets and liabilities, except for items that are
recognized or disclosed at fair value in the financial statements on a recurring basis (at least
annually). The adoption did not have a significant impact on our unaudited consolidated financial
statements.
In the quarter ended June 30, 2009, we adopted the authoritative guidance issued by the FASB
that changes the accounting and reporting for noncontrolling interests. The guidance establishes
accounting and reporting standards to improve the relevance, comparability and transparency of
financial information that a reporting entity provides in its consolidated financial statements.
The guidance is not presently applicable to us.
In the quarter ended June 30, 2009, we adopted the authoritative guidance issued by the FASB
on determining fair value when the volume and level of activity for an asset or liability has
significantly decreased, and on identifying transactions that are not orderly. Based on the
guidance, if an entity determines that the level of activity for an asset or liability has
significantly decreased and that a transaction is not orderly, further analysis of transactions or
quoted prices is needed, and a significant adjustment to the transaction or quoted prices may be
necessary to estimate fair value. The adoption did not have any impact on our unaudited condensed
consolidated financial statements.
6
Table of Contents
In December 2008, the FASB issued authoritative guidance on employers disclosures about
postretirement benefit plan assets. The guidance requires more detailed annual disclosures about
employers plan assets, including employers investment strategies, major categories of plan
assets, concentrations of risk within plan assets and valuation techniques used to measure the fair
value of plan assets. The guidance does not change the accounting treatment for postretirement
benefits plans and is effective for us for the fiscal year ended March 31, 2010, or fiscal 2010.
In the quarter ended June 30, 2009, we adopted the authoritative guidance issued by the FASB
on recognition and presentation of other-than-temporary impairment. The guidance amends the
other-than-temporary impairment guidance for debt securities to make the guidance more operational
and to improve the presentation and disclosure of other-than-temporary impairments in the financial
statements. The guidance also clarifies the interaction of the factors that should be considered
when determining whether a debt security is other-than-temporarily impaired. The adoption did not
have any impact on our unaudited condensed consolidated financial statements.
In the quarter ended June 30, 2009, we adopted the authoritative guidance issued by the FASB
on interim disclosure about fair value of financial instruments. The guidance requires disclosures
about fair value of financial instruments for interim reporting periods of publicly traded
companies as well as in annual financial statements. Additionally, the guidance requires disclosure
of the methods and significant assumptions used to estimate the fair value of financial instruments
on an interim basis as well as changes of methods and significant assumptions from prior periods.
The guidance does not change the accounting treatment for these financial instruments and the
adoption did not have significant impact on our unaudited condensed consolidated financial
statements.
In June 2009, the FASB issued authoritative guidance on the consolidation of variable interest
entities. The guidance eliminates a required quantitative approach to determine whether a variable
interest gives the entity a controlling financial interest in a variable interest entity in favor
of a qualitatively focused analysis. It requires an ongoing reassessment of whether an entity is
the primary beneficiary. The guidance is effective for us beginning in the quarter ending June 30,
2010. We are currently evaluating the impact that the adoption of the guidance will have on our
condensed consolidated financial statements.
In the quarter ended September 30, 2009, we adopted the authoritative guidance issued by FASB
on fair value measurements and disclosures. The guidance provides clarification that in
circumstances in which a quoted price in an active market for the identical liability is not
available, a reporting entity is required to measure fair value using certain defined valuation
techniques. The adoption of the guidance did not have significant impacts on our unaudited
condensed consolidated financial statements.
3. Business Combination
Leadis Technology Inc.
On September 14, 2009, we completed the acquisition of the assets and certain associated
intellectual property of the LED driver and display driver businesses of Leadis. The acquisition
was intended to expand our market opportunity in the LED market.
The total consideration for the acquisition was $3.5 million, of which $2.6 million was paid
in cash. The balance of the consideration, $875,000, net of adjustments arising after the closing
date, is included in our accounts payable balance and will be paid in March 2010. We also purchased
inventory for cash consideration of $569,000. The following table represents the preliminary
purchase price allocation of assets acquired on the closing date of the acquisition (in thousands):
Preliminary | Estimated | |||||||
Purchase Price | Useful Life | |||||||
Allocation | (in months) | |||||||
Intangible assets: | ||||||||
Existing technology |
$ | 1,200 | 24 | |||||
Customer relationships |
210 | 24 | ||||||
Contract backlog |
1,170 | 12 | ||||||
Non-compete agreement |
20 | 24 | ||||||
Trade name |
210 | 24 | ||||||
Total intangible assets |
2,810 | |||||||
Goodwill |
690 | |||||||
Total purchase price |
$ | 3,500 | ||||||
Goodwill represents the excess of purchase price of an acquired business over the fair value
of the underlying intangible assets. Since these assets were acquired by an entity with a favorable
tax ruling, goodwill will not result in any effective tax benefit. The primary item that generated
the goodwill is the value of the synergies between the acquired businesses and our previously
existing
7
Table of Contents
business, which does not qualify as an amortizable intangible asset. The fair value of the
amortizable intangible assets was determined using the income approach, royalty savings approach
and cost approach. As of December 31, 2009, we have incurred $134,000 in legal and consulting costs
related to the acquisition. The costs incurred have been fully expensed and are included in
Selling, general and administrative expenses on our unaudited condensed consolidated statements
of operations.
The consolidated financial statements include the operating results of the acquired businesses
from the date of acquisition. The earnings and the pro-forma financial information have not been
presented because the effect of this acquisition was not material to our financial results.
Zilog Inc.
On December 5, 2009, we entered into a definitive agreement to acquire Zilog Inc., or Zilog, a
supplier of application specific, embedded microcontroller units that are system-on-chip solutions
for industrial and consumer markets. See Note 16, Commitments and Contingencies for further
information regarding the acquisition.
4. Restructuring Charges
In the quarter ended September 30, 2009, we initiated plans to restructure our European
manufacturing and assembly operations to align them to current market conditions. The plans
primarily involved the termination of employees and centralization of certain positions. Costs
related to termination of employees represented severance payments and benefits. The restructuring
charges recorded in conjunction with the plans represented severance costs and have been included
under Restructuring charges in our unaudited condensed consolidated statements of operations. The
restructuring accrual as of December 31, 2009 was included under Accrued expenses and other
current liabilities on our unaudited condensed consolidated balance sheets.
Restructuring activity as of and for the three and nine months ended December 31, 2009 was as
follows (in thousands):
Severance and | ||||
Related Benefits | ||||
Charges |
$ | 1,010 | ||
Cash payments |
(176 | ) | ||
Currency translation adjustment |
2 | |||
Balance at September 30, 2009 |
$ | 836 | ||
Charges |
32 | |||
Cash payments |
(46 | ) | ||
Currency translation adjustment |
(11 | ) | ||
Balance at December 31, 2009 |
$ | 811 | ||
We anticipate that the remaining restructuring obligations of $811,000 as of December 31, 2009
will be substantially paid by June 30, 2010.
5. Fair Value
We account for certain assets and liabilities at fair value. In determining fair value, we
consider its principal or most advantageous market and the assumptions that market participants
would use when pricing, such as inherent risk, restrictions on sale and risk of nonperformance. The
fair value hierarchy is based upon the observability of inputs used in valuation techniques.
Observable inputs (highest level) reflect market data obtained from independent sources, while
unobservable inputs (lowest level) reflect internally developed market assumptions. The fair value
measurements are classified under the following hierarchy:
Level 1 | | Quoted prices for identical instruments in active markets. | ||||
Level 2 | | Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs or significant value-drivers are observable in active markets. | ||||
Level 3 | | Model-derived valuations in which one or more significant inputs or significant value-drivers are unobservable. |
Assets measured at fair value on a recurring basis, excluding accrued interest components,
consisted of the following types of instruments as of December 31, 2009 and March 31, 2009 (in
thousands):
8
Table of Contents
December 31, 2009 (1) | March 31, 2009 (1) | |||||||||||||||||||||||
Fair Value Measured at | Fair Value Measured at | |||||||||||||||||||||||
Reporting Date Using | Reporting Date Using | |||||||||||||||||||||||
Total | Level 1 | Level 2 | Total | Level 1 | Level 2 | |||||||||||||||||||
(unaudited) | (unaudited) | |||||||||||||||||||||||
Assets |
||||||||||||||||||||||||
Marketable equity securities (2) |
$ | 216 | $ | 216 | $ | | $ | 525 | $ | 525 | $ | | ||||||||||||
Derivative contract (3) |
(170 | ) | | (170 | ) | (124 | ) | | (124 | ) | ||||||||||||||
Total assets measured at fair value |
$ | 46 | $ | 216 | $ | (170 | ) | $ | 401 | $ | 525 | $ | (124 | ) | ||||||||||
(1) | We did not have any assets whose fair value was measured using significant unobservable inputs. | |
(2) | Included in other assets on our unaudited condensed consolidated balance sheets. | |
(3) | Included in prepaid expenses and other current assets on our unaudited condensed consolidated balance sheets. |
We measure our marketable securities and derivative contracts at fair value. Marketable
securities are valued using the quoted market prices and are therefore classified as Level 1
estimates.
We use derivative instruments to manage exposures to changes in foreign currency exchange
rates and interest rates, and the fair values of these instruments are recorded on the balance
sheets. We have elected not to designate these instruments as accounting hedges. The changes in the
fair value of these instruments are recorded in the current periods income statement and are
included in other income (expense), net. All of our derivative instruments are traded on
over-the-counter markets where quoted market prices are not readily available. For those
derivatives, we measure fair value using prices obtained from the counterparties with whom we have
traded. The counterparties price the derivatives based on models that use primarily market
observable inputs, such as yield curves and option volatilities. Accordingly, we classify these
derivatives as Level 2. See Note 9, Borrowing Arrangements for further information regarding the
terms of the derivative contract. We did not enter into any new derivative contracts in the three
and nine months ended December 31, 2009.
Cash and cash equivalents are recognized and measured at fair value in our consolidated
financial statements. Accounts receivable and prepaid expenses and other current assets are
financial assets with carrying values that approximate fair value. Accounts payable and accrued
expenses and other current liabilities are financial liabilities with carrying values that
approximate fair value.
Long term loans, which primarily consist of notes from banks, approximate fair value as the
interest rates either adjust according to the market rates or the interest rates approximate the
market rates at December 31, 2009. See Note 10, Pension Plans for a discussion of pension
liabilities.
6. Inventories
Inventories consist of the following (in thousands):
December 31, | March 31, | |||||||
2009 | 2009 | |||||||
(unaudited) | ||||||||
Raw materials |
$ | 14,206 | $ | 14,431 | ||||
Work in process |
34,135 | 39,916 | ||||||
Finished goods |
17,037 | 21,254 | ||||||
Total |
$ | 65,378 | $ | 75,601 | ||||
7. Other Assets
Other assets consist of the following (in thousands):
9
Table of Contents
December 31, | March 31, | |||||||
2009 | 2009 | |||||||
(unaudited) | ||||||||
Available-for-sale investment securities |
$ | 216 | $ | 525 | ||||
Long term equity investment |
4,739 | 4,183 | ||||||
Goodwill |
690 | | ||||||
Intangible assets, net |
2,466 | 256 | ||||||
Advance to vendors and other items |
1,491 | 1,764 | ||||||
Total |
$ | 9,602 | $ | 6,728 | ||||
Other assets include goodwill and intangible assets acquired from Leadis in September 2009.
See Note 3, Business Combination for further information regarding the acquisition, goodwill,
intangible assets and the estimated useful life of these assets.
8. Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consist of the following (in thousands):
December 31, | March 31, | |||||||
2009 | 2009 | |||||||
(unaudited) | ||||||||
Uninvoiced goods and services |
$ | 5,671 | $ | 5,755 | ||||
Compensation and benefits |
4,203 | 5,916 | ||||||
Restructuring accrual |
811 | | ||||||
Commission, royalties, deferred revenue and other |
3,004 | 3,671 | ||||||
Total |
$ | 13,689 | $ | 15,342 | ||||
9. Borrowing Arrangements
Bank of the West
On November 13, 2009, we entered into a credit agreement, for a revolving line of credit with
Bank of the West, or BOW, under which we may borrow up to $15.0 million. Borrowings may be repaid
and re-borrowed during the term of the credit agreement. The obligations are guaranteed by two of
our subsidiaries. All amounts owed under the credit agreement are due and payable on October 31,
2011. On November 16, 2009, we borrowed $15.0 million pursuant to the credit agreement.
The credit agreement provides different interest rate alternatives under which we may borrow
funds. We may elect to borrow based on LIBOR plus a margin, an alternative base rate plus a margin
or a floating rate plus a margin. The margin can range from 1.5% to 3.25%, depending on interest
rate alternatives and on our leverage of liabilities to effective tangible net worth.
For the initial period, we chose a six-month LIBOR commitment, resulting in an interest rate,
inclusive of BOWs margin, of 3.0625% per annum. During the quarter ended December 31, 2009,
monthly interest of approximately $40,000 was paid to BOW.
The credit agreement is subject to a set of financial covenants, including minimum effective
tangible net worth, the ratio of cash, cash equivalents and accounts receivable to current
liabilities, profitability beginning with the quarter ended June 30, 2010, maximum losses in the
fiscal quarters before such quarter, a ratio of EBITDA to interest expense and a minimum amount of
U.S. domestic cash on hand. At December 31, 2009, we complied with the financial covenants.
The credit agreement also includes a $3.0 million letter of credit subfacility commencing
April 1, 2010. See Note 16, Commitment and Contingencies for further information regarding the
terms of the subfacility.
IKB Deutsche Industriebank
On June 10, 2005, IXYS Semiconductor GmbH, our German subsidiary, borrowed 10.0 million,
or about $12.2 million at the time, from IKB Deutsche Industriebank for a term of 15 years. The
outstanding balance at December 31, 2009 was 7.0 million, or $10.0 million.
10
Table of Contents
The interest rate on the loan is determined by adding the then effective three month Euribor
rate and a margin. The margin can range from 70 basis points to 125 basis points, depending on the
calculation of a ratio of indebtedness to cash flow for our German subsidiary.
We have entered into an interest rate swap to economically hedge the interest rate risk. Under
the swap arrangement, during the first five years of the loan, if the Euribor rate exceeds 3.75%,
then the Euribor rate for the purposes of the loan shall be 4.1%, and, if the Euribor rate falls
below 2.0%, then the Euribor rate for the purposes of the loan shall be 3.0%. The effective
interest rate at December 31, 2009 was 3.7%. The swap agreement expires on June 30, 2010 and is not
designated as a hedge in the financial statements. See Note 5, Fair Value for further information
regarding the derivative contract.
During each fiscal quarter, a principal payment of 167,000, or about $239,000, and a
payment of accrued interest are required.
Financial covenants for a ratio of indebtedness to cash flow, a ratio of equity to total
assets and a minimum stockholders equity for the German subsidiary must be satisfied for the loan
to remain in good standing. The loan may be prepaid in whole or in part at the end of a fiscal
quarter without penalty. At December 31, 2009, we complied with the financial covenants. The loan
is partially collateralized by a security interest in the facility owned by IXYS in Lampertheim,
Germany.
LaSalle Bank National Association
On August 2, 2007, IXYS Buckeye, LLC, a subsidiary of our company, entered into an Assumption
Agreement with LaSalle Bank National Association, trustee for Morgan Stanley Dean Witter Capital I
Inc., for the assumption of a loan of $7.5 million in connection with the purchase of property in
Milpitas, California. The loan carries a fixed annual interest rate of 7.455%. Monthly payments of
principal and interest of $56,000 are due under the loan. In addition, monthly impound payments
aggregating $14,000 are to be made for items such as real property taxes, insurance and capital
expenditures. The loan is due and payable on February 1, 2011. At maturity, the remaining balance
on the loan will be approximately $7.1 million. The loan is secured by a guarantee from our company
and collateralized by a security interest in the property acquired. Aggregate loan costs of $93,000
incurred in connection with the loan are amortized over the loan period and the unamortized balance
is netted against the loan liability.
Note payable issued on acquisition
On September 10, 2008, we issued a note payable with a face value of $2.0 million in
connection with the purchase of real property and the acquisition of the shares of Reaction
Technology Incorporated, or RTI. The note is repayable in 60 equal monthly installments of $38,666,
which includes interest at an annual rate of 6.0%. The note is collateralized by a security
interest in the property acquired and the current assets of RTI.
10. Pension Plans
We maintain two defined benefit pension plans: one for United Kingdom employees and one for
German employees. These plans cover most of the employees in the United Kingdom and Germany.
Benefits are based on years of service and the employees compensation. We deposit funds for these
plans, consistent with the requirements of local law, with investment management companies,
insurance companies or trustees and/or accrue for the unfunded portion of the obligations. The
measurement date for the projected benefit obligations and the plan assets is March 31. Both plans
have been curtailed. As such, the plans are closed to new entrants and no credit is provided for
additional periods of service.
The net periodic pension expense includes the following components (in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Service cost |
$ | | $ | | $ | | $ | | ||||||||
Interest cost on projected
benefit obligation |
497 | 507 | 1,458 | 1,734 | ||||||||||||
Expected return on plan assets |
(257 | ) | (377 | ) | (759 | ) | (1,300 | ) | ||||||||
Recognized actuarial loss |
31 | 20 | 91 | 69 | ||||||||||||
Net periodic pension expense |
$ | 271 | $ | 150 | $ | 790 | $ | 503 | ||||||||
We expect to contribute approximately $625,000 to the plans in the fiscal year ending March
31, 2010. This contribution is primarily contractual.
11
Table of Contents
11. Employee Equity Incentive Plans
Stock Purchase and Stock Option Plans
On June 5, 2009, the Board of Directors approved the adoption of the 2009 Equity Incentive
Plan, or the 2009 Plan, under which 900,000 shares of our common stock are reserved for the grant
of stock options. On September 10, 2009, our stockholders approved the 2009 Plan.
Employee Stock Purchase Plan
In May 1999, the Board of Directors approved the 1999 Employee Stock Purchase Plan, or the
Purchase Plan, and reserved 500,000 shares of common stock for issuance under the Purchase Plan.
Under the Purchase Plan, all eligible employees may purchase our common stock at a price equal to
85% of the lower of the fair market value at the beginning of the offer period or the semi-annual
purchase date. Stock purchases are limited to 15% of an employees eligible compensation. On July
31, 2007, the Board of Directors amended the Purchase Plan and reserved an additional 350,000
shares of common stock for issuance under the Purchase Plan. During the three and nine months ended
December 31, 2009, there were 45,306 and 86,668 shares purchased under the Purchase Plan, leaving
approximately 148,000 shares available for purchase under the plan in the future.
Stock-Based Compensation
The following table summarizes the effects of stock-based compensation charges (in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
Income Statement Classifications | (unaudited) | (unaudited) | ||||||||||||||
Selling, general and administrative expenses |
$ | 702 | $ | 753 | $ | 2,443 | $ | 1,925 | ||||||||
Stock-based compensation effect in income
before taxes |
702 | 753 | 2,443 | 1,925 | ||||||||||||
Provision for income taxes (1) |
267 | 271 | 928 | 693 | ||||||||||||
Net stock-based compensation effects in net
income (loss) |
$ | 435 | $ | 482 | $ | 1,515 | $ | 1,232 | ||||||||
(1) | Estimated at a statutory income tax rate of 38% in fiscal year 2010 and 36% in fiscal year 2009. |
During the three and nine months ended December 31, 2009, the unaudited condensed consolidated
statements of operations and cash flows do not reflect any tax benefit for the tax deduction from
option exercises and other awards. As of December 31, 2009, approximately $5.6 million in stock
based compensation is to be recognized for unvested stock options granted under our equity
incentive plans. The unrecognized compensation cost is expected to be recognized over a weighted
average period of 2.4 years.
The Black-Scholes option pricing model is used to estimate the fair value of options granted
under our equity incentive plans and rights to acquire stock granted under our stock purchase plan.
The weighted average estimated fair values of employee stock option grants and rights granted under
the 1999 Employee Stock Purchase Plan, as well as the weighted average assumptions that were used
in calculating such values during the three and nine months ended December 31, 2009 and 2008, were
based on estimates at the date of grant as follows:
12
Table of Contents
Stock Options | Purchase Plan | |||||||||||||||||||||||||||
Three months | Nine months | Three months | Nine months | |||||||||||||||||||||||||
ended | ended | ended | ended | |||||||||||||||||||||||||
December 31, | December 31, | December 31, | December 31, | |||||||||||||||||||||||||
2008 (1) | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | ||||||||||||||||||||||
Weighted average estimated
fair
value of grant per share |
$ | 2.94 | $ | 3.49 | $ | 3.38 | $ | 3.20 | $ | 5.28 | $ | 4.19 | $ | 4.21 | ||||||||||||||
Risk-free interest rate |
2.3 | % | 2.3 | % | 2.4 | % | 0.3 | % | 2.0 | % | 0.4 | % | 2.6 | % | ||||||||||||||
Expected term in years |
4.6 | 5.0 | 4.6 | 0.5 | 0.5 | 0.5 | 0.5 | |||||||||||||||||||||
Volatility |
51.6 | % | 57.0 | % | 50.4 | % | 53.2 | % | 96.1 | % | 80.1 | % | 77.8 | % | ||||||||||||||
Dividend yield |
0 | % | 0 | % | 0 | % | 0 | % | 0 | % | 0 | % | 0 | % |
(1) | No stock options were granted during the quarter ended December 31, 2009. |
Activity with respect to outstanding stock options for the nine months ended December 31, 2009
was as follows:
Weighted | ||||||||||||
Number of | Average Exercise | Intrinsic | ||||||||||
Shares | Price Per Share | Value (1) | ||||||||||
(000) | ||||||||||||
Balance at March 31, 2009 |
6,063,569 | $ | 8.42 | |||||||||
Options granted |
100,000 | $ | 6.88 | |||||||||
Options exercised |
(805,300 | ) | $ | 2.80 | $ | 3,837 | ||||||
Options cancelled |
(46,250 | ) | $ | 7.11 | ||||||||
Options expired |
(37,323 | ) | $ | 12.42 | ||||||||
Balance at December 31, 2009 |
5,274,696 | $ | 9.23 | |||||||||
Exercisable at December 31, 2009 |
3,489,071 | $ | 9.89 | |||||||||
Exercisable at March 31, 2009 |
3,635,269 | $ | 8.61 |
(1) | Represents the difference between the exercise price and the value of IXYS stock at the time of exercise. |
Activity with respect to outstanding restricted stock units for the nine months ended December
31, 2009 was as follows:
Weighted | ||||||||||||
Number of | Average Grant | Aggregate | ||||||||||
Shares | Date Fair Value | Fair Value (1) | ||||||||||
(000) | ||||||||||||
Balance at March 31, 2009 |
64,900 | $ | 9.58 | |||||||||
RSUs vested (2) |
(32,450 | ) | $ | 9.58 | $ | 251 | ||||||
RSUs forfeited |
(250 | ) | $ | 9.73 | $ | 2 | ||||||
Balance at December 31, 2009 |
32,200 | $ | 9.58 |
(1) | For RSUs, represents value of IXYS stock on the date the restricted stock unit vests. | |
(2) | The number of restricted stock units vested includes shares that were withheld on behalf of employees to satisfy the statutory tax withholding requirements. |
12. Comprehensive Income
The components of total comprehensive income (loss) and related tax effects were as follows
(in thousands):
13
Table of Contents
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Net income (loss) |
$ | 399 | $ | (3,982 | ) | $ | (4,699 | ) | $ | 7,561 | ||||||
Unrealized gain (loss) on available-for-sale
investment securities,
net of taxes of $4 and $22 for the three and
nine months ended
December 31, 2009 and net of taxes of $(30) and
$(273) for
the three and nine months ended December 31, 2008 |
7 | (59 | ) | 41 | (529 | ) | ||||||||||
Foreign currency translation adjustments |
(1,053 | ) | (4,274 | ) | 5,667 | (10,912 | ) | |||||||||
Total comprehensive income (loss) |
$ | (647 | ) | $ | (8,315 | ) | $ | 1,009 | $ | (3,880 | ) | |||||
The components of accumulated other comprehensive income, net of tax, at the end of each
period were as follows (in thousands):
December 31, | March 31, | |||||||
2009 | 2009 | |||||||
(unaudited) | ||||||||
Accumulated net unrealized gain (loss) on available-for-sale
investments securities,
net of taxes of $20 at December 31, 2009 and $(2) at March 31, 2009 |
$ | 37 | $ | (4 | ) | |||
Unrecognized actuarial loss, net of tax of $942 |
(2,422 | ) | (2,422 | ) | ||||
Accumulated foreign currency translation adjustments |
10,063 | 4,396 | ||||||
Total accumulated other comprehensive income |
$ | 7,678 | $ | 1,970 | ||||
13. Computation of Net Income (Loss) per Share
Basic and diluted earnings (loss) per share are calculated as follows (in thousands, except per
share amounts):
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Basic: |
||||||||||||||||
Weighted average shares |
31,100 | 30,979 | 30,893 | 31,238 | ||||||||||||
Net income (loss) |
$ | 399 | $ | (3,982 | ) | $ | (4,699 | ) | $ | 7,561 | ||||||
Net income (loss) per share |
$ | 0.01 | $ | (0.13 | ) | $ | (0.15 | ) | $ | 0.24 | ||||||
Diluted: |
||||||||||||||||
Weighted average shares |
31,100 | 30,979 | 30,893 | 31,238 | ||||||||||||
Common equivalent shares from stock options |
169 | | | 998 | ||||||||||||
Weighted average shares used in diluted
per share calculation |
31,269 | 30,979 | 30,893 | 32,236 | ||||||||||||
Net income (loss) |
$ | 399 | $ | (3,982 | ) | $ | (4,699 | ) | $ | 7,561 | ||||||
Net income (loss) per share |
$ | 0.01 | $ | (0.13 | ) | $ | (0.15 | ) | $ | 0.23 | ||||||
Basic net income (loss) available per common share is computed using net income (loss) and the
weighted average number of common shares outstanding during the period. Diluted net income (loss)
per common share is computed using net income (loss) and the weighted average number of common
shares outstanding, assuming dilution, which includes potentially dilutive common shares
outstanding during the period. Potentially dilutive common shares include the assumed exercise of
stock options and assumed vesting of restricted stock units using the treasury stock method. For
the quarter ended December 31, 2009, we excluded 4.7 million outstanding stock options from the
calculation of net income per share because the exercise price of these stock options were greater
than or equal to the average market value of the common shares. These options could be included in
the calculation in the future, if the average market value of the common shares increases and is
greater than the exercise price of these options. Due to our net loss for the nine months ended
December 31, 2009, outstanding stock options and restricted stock units to purchase 1.1 million
shares of our common stock were excluded from the diluted net loss per share calculation because
their inclusion would have been anti-dilutive.
14
Table of Contents
Similarly, due to our net loss for the quarter ended
December 31, 2008, outstanding stock options and restricted stock units to purchase 1.4 million of
our common stock were excluded from the diluted net loss per share calculation. For the nine months
ended December 31, 2008, there were outstanding stock options and restricted stock units to
purchase 3.9 million shares that were not included in the computation of dilutive net income per
share since the exercise price of the options were greater than or equal to the average market
price of the common stock.
14. Segment Information
We have a single operating segment. This operating segment is comprised of semiconductor
products used primarily in power-related applications. While we have separate legal subsidiaries
with discrete financial information, we have one chief operating decision maker with highly
integrated businesses. Our sales by major geographic area (based on destination) were as follows
(in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
United States |
$ | 17,315 | $ | 17,507 | $ | 49,731 | $ | 60,532 | ||||||||
Europe and the Middle East |
||||||||||||||||
France |
1,297 | 1,491 | 3,104 | 5,803 | ||||||||||||
Germany |
6,807 | 8,153 | 18,571 | 32,269 | ||||||||||||
Italy |
1,119 | 1,520 | 2,712 | 6,044 | ||||||||||||
Sweden |
1,178 | 445 | 2,908 | 3,521 | ||||||||||||
United Kingdom |
3,770 | 3,511 | 9,808 | 13,690 | ||||||||||||
Other |
7,000 | 7,597 | 18,251 | 27,657 | ||||||||||||
Asia Pacific |
||||||||||||||||
China |
14,584 | 6,534 | 32,787 | 25,213 | ||||||||||||
Japan |
3,145 | 1,852 | 7,364 | 7,197 | ||||||||||||
Korea |
2,216 | 1,527 | 5,114 | 5,882 | ||||||||||||
Other |
2,887 | 4,378 | 8,525 | 13,470 | ||||||||||||
Rest of the World |
||||||||||||||||
India |
1,631 | 2,275 | 4,721 | 9,437 | ||||||||||||
Other |
1,083 | 1,547 | 3,067 | 4,593 | ||||||||||||
Total |
$ | 64,032 | $ | 58,337 | $ | 166,663 | $ | 215,308 | ||||||||
The following table sets forth net revenues for each of our product groups for the three and
nine months ended December 31, 2009 and 2008 (in thousands):
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Power semiconductors |
$ | 43,662 | $ | 45,318 | $ | 122,999 | $ | 170,669 | ||||||||
Integrated circuits |
15,306 | 7,533 | 29,997 | 24,945 | ||||||||||||
Systems and RF power semiconductors |
5,064 | 5,486 | 13,667 | 19,694 | ||||||||||||
Total |
$ | 64,032 | $ | 58,337 | $ | 166,663 | $ | 215,308 | ||||||||
For the three and nine months ended December 31, 2009, one customer accounted for 10.4%
and 11.3% of our net revenues. For the three and nine months ended December 31, 2008, no customer
accounted for more than 10% of our net revenues.
15. Income Taxes
For the three and nine months ended December 31, 2009, we recorded income tax provisions of
$1.7 million and $347,000. For the three and nine months ended December 31, 2008, we recorded an
income tax benefit of $1.3 million and an income tax provision of
15
Table of Contents
$4.9 million, respectively. For
the three months ended December 31, 2009, the provision for income tax represented the adjustment
of the income tax account to reflect a change in our estimated income taxes for the year based on
nine months of experience, offset by a favorable impact on the reversal of accrued tax expenses of
$350,000 following the conclusion of an audit in a foreign tax jurisdiction. The provision for
income tax for the nine months ended December 31, 2009 was incurred because we had profits in
certain jurisdictions and losses in jurisdictions with comparatively lower tax rates, partially
offset by the release of valuation allowances. For the three and nine months ended December 31,
2008, our accounting for income tax was affected by permanent items, including the goodwill
impairment, net of a valuation allowance release.
16. Commitments and Contingencies
Legal Proceedings
We are currently involved in a variety of legal matters that arise in the normal course of
business. Were an unfavorable ruling to occur, there could be a material adverse impact on our
financial condition, results of operations or cash flows.
Bank of the West
In September 2009, we entered in an agreement with BOW for a letter of credit facility of $3.0
million. The facility expires on March 31, 2010. At December 31, 2009, there was an open letter of
credit with a balance of $52,000 to support inventory purchases.
On November 13, 2009, we entered into a credit agreement with BOW. The credit agreement
includes a letter of credit subfacility, under which BOW agrees to issue letters of credit of up to
$3.0 million upon the expiration of the current facility on March 31, 2010. However, borrowing
under this subfacility is limited to the extent of availability under the $15.0 million revolving
line of credit. The credit agreement expires on October 31, 2011. See Note 9, Borrowing
Arrangements for further information regarding the terms of the credit agreement.
Zilog Inc.
On December 5, 2009, we entered into a definitive agreement to acquire Zilog. Under the terms
of the agreement, we will acquire all of the Zilogs outstanding common shares for $3.5858 per
share in cash. Payment for shares and for stock options is expected to aggregate approximately
$62.4 million. The acquisition is subject to the approval of Zilog shareholders and other customary
closing
conditions. The transaction is expected to be completed during the quarter ended March 31,
2010. See Note 3, Business Combination for further information regarding the acquisition.
Other Commitments and Contingencies
On occasion, we provide limited indemnification to customers against intellectual property
infringement claims related to our products. To date, we have not experienced significant activity
or claims related to such indemnifications. We also provide in the normal course of business
indemnification to our officers, directors and selected parties. We are unable to estimate any
potential future liability, if any. Therefore, no liability for these indemnification agreements
has been recorded as of December 31, 2009 and March 31, 2009.
16
Table of Contents
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This discussion contains forward-looking statements, which are subject to certain risks and
uncertainties, including, without limitation, those described elsewhere in this Form 10-Q and, in
particular, in Item 1A of Part II hereof. Actual results may differ materially from the results
discussed in the forward-looking statements. For a discussion of risks that could affect future
results, see Item 1A. Risk Factors. All forward-looking statements included in this document are
made as of the date hereof, based on the information available to us as of the date hereof, and we
assume no obligation to update any forward-looking statement, except as may be required by law.
Overview
We are a multi-market integrated semiconductor company. Our three principal product groups
are: power semiconductors; integrated circuits, or ICs; and systems and radio frequency, or RF,
power semiconductors.
Our power semiconductors improve system efficiency and reliability by converting electricity
at relatively high voltage and current levels into the finely regulated power required by
electronic products. We focus on the market for power semiconductors that are capable of processing
greater than 200 watts of power.
We also design, manufacture and sell integrated circuits for a variety of applications. Our
analog and mixed signal ICs are principally used in telecommunications applications. Our mixed
signal application specific ICs, or ASICs, address the requirements of the medical imaging
equipment and display markets. Our power management and control ICs are used in conjunction with
power semiconductors.
Our systems include laser diode drivers, high voltage pulse generators and modulators, and
high power subsystems, sometimes known as stacks, that are principally based on our high power
semiconductor devices. Our RF power semiconductors enable circuitry that amplifies or receives
radio frequencies in wireless and other microwave communication applications, medical imaging
applications and defense and space applications.
Over the past two quarters, our revenues from the sale of ICs have increased significantly,
primarily through sales to the consumer product market, while our revenues from the sales of power
semiconductors and RF power semiconductors have increased modestly. Distribution revenues increased
because of the growth of sales to the consumer product market. Geographically, over the same
periods, sales to all major geographic areas increased except North America. Our sales to all major
market segments increased except the medical market. Our selling, general and administrative
expenses, or SG&A expenses, continued to be relatively flat. In the quarter ended December 31,
2009, as compared to the immediately preceding quarter, our research, development and engineering
expenses, or R&D expenses, increased as a result of the acquisition of the display driver business
from Leadis Technology Inc. In future periods, both our SG&A and R&D expenses are expected to
continue at approximately these levels. Because of continued economic volatility, our visibility
regarding the future remains uncertain, although orders received for our products did strengthen in
the quarter ended December 31, 2009.
Critical Accounting Policies and Significant Management Estimates
The discussion and analysis of our financial condition and results of operations is based upon
our consolidated financial statements, which have been prepared in accordance with accounting
principles generally accepted in the United States of America. The preparation of these financial
statements requires management to make estimates and judgments that affect the reported amounts of
assets, liabilities, revenues and expenses, and related disclosures of contingent assets and
liabilities. On an ongoing basis, management evaluates the reasonableness of its estimates.
Management bases its estimates on historical experience and on various assumptions that are
believed to be reasonable under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities that are not readily available from
other sources. Actual results may differ materially from these estimates under different
assumptions or conditions.
We believe the following critical accounting policies require that we make significant
judgments and estimates in preparing our consolidated financial statements.
Revenue recognition. We sell to distributors and original equipment manufacturers.
Approximately 49.7% of our revenues in the nine months ended December 31, 2009 and 46.5% of our
revenues in the nine months ended December 31, 2008 were from distributors. We provide some of our
distributors with the following programs: stock rotation and ship and debit. Ship and debit is a
sales incentive program for products previously shipped to distributors. We recognize revenue from
product sales upon shipment provided that we have received a valid purchase order, the price is
fixed and determinable, the risk of loss has transferred, collection of resulting receivable is
reasonable assured, there are no customer acceptance requirements and there are no remaining
significant
17
Table of Contents
obligations. Our shipping terms are generally FOB shipping point. Reserves for allowances are
also recorded at the time of shipment. Our management must make estimates of potential future
product returns and so called ship and debit transactions related to current period product
revenue. Our management analyzes historical returns and ship and debit transactions, current
economic trends and changes in customer demand and acceptance of our products when evaluating the
adequacy of the sales returns and allowances. Significant management judgments and estimates must
be made and used in connection with establishing the allowances in any accounting period. We have
visibility into inventory held by our distributors to aid in our reserve analysis. Different
judgments or estimates would result in material differences in the amount and timing of our revenue
for any period.
Accounts receivable from distributors are recognized and inventory is relieved when title to
inventories transfer, typically upon shipment from our company, at which point we have a legally
enforceable right to collection under normal payment terms. Under certain circumstances, where our
management is not able to reasonably and reliably estimate the actual returns, revenues and costs
relating to distributor sales are deferred until products are sold by the distributors to their end
customers. Deferred amounts are presented net and included under accrued expenses and other
liabilities in our unaudited condensed consolidated financial statements.
We state our revenues net of taxes collected from our customers that are required to be
remitted to the various government agencies. The amount of taxes collected from customers and
payable to government is included under accrued expenses and other liabilities. Shipping and
handling costs are included in cost of sales.
Allowance for sales returns. We maintain an allowance for sales returns for estimated product
returns by our customers. We estimate our allowance for sales returns based on our historical
return experience, current economic trends, changes in customer demand, known returns we have not
received and other assumptions. If we were to make different judgments or utilize different
estimates, the amount and timing of our revenue could be materially different. Given that our
revenues consist of a high volume of relatively similar products, to date our actual returns and
allowances have not fluctuated significantly from period to period and our returns provisions have
historically been reasonably accurate. This allowance is included as part of the accounts
receivable allowance on the balance sheet and as a reduction of revenues in the statement of
operations.
Allowance for stock rotation. We also provide stock rotation to select distributors. The
rotation allows distributors to return a percentage of the previous six months sales in exchange
for orders of an equal or greater amount. In the nine months ended December 31, 2009 and 2008,
approximately $1.0 million and $1.6 million, respectively, of products were returned to us under
the program. We generally establish the allowance for all sales to distributors except in cases
where the revenue recognition is deferred and recognized upon sale by the distributor of products
to the end customer. The allowance, which is managements best estimate of future returns, is based
upon the historical experience of returns and inventory levels at the distributors. This allowance
is included as part of the accounts receivable allowance on the balance sheet and as a reduction of
revenues in the statement of operations. Should distributors increase stock rotations beyond our
estimates, our financial statements would be adversely affected.
Allowance for ship and debit. Ship and debit is a program designed to assist distributors in
meeting competitive prices in the marketplace on sales to their end customers. Ship and debit
requires a request from the distributor for a pricing adjustment for a specific part for a customer
sale to be shipped from the distributors stock. We have no obligation to accept this request.
However, it is our historical practice to allow some companies to obtain pricing adjustments for
inventory held. We receive periodic statements regarding our products held by our distributors. Our
distributors had approximately $3.7 million in inventory of our products on hand at December 31,
2009. Ship and debit authorizations may cover current and future distributor activity for a
specific part for sale to the distributors customer. At the time we record sales to the
distributors, we provide an allowance for the estimated future distributor activity related to such
sales since it is probable that such sales to distributors will result in ship and debit activity.
The sales allowance requirement is based on sales during the period, credits issued to
distributors, distributor inventory levels, historical trends, market conditions, pricing trends we
see in our direct sales activity with original equipment manufacturers and other customers, and
input from sales, marketing and other key management. We believe that the analysis of these inputs
enable us to make reliable estimates of future credits under the ship and debit program. This
analysis requires the exercise of significant judgments. Our actual results to date have
approximated our estimates. At the time the distributor ships the part from stock, the distributor
debits us for the authorized pricing adjustment. This allowance is included as part of the accounts
receivable allowance on the balance sheet and as a reduction of revenues in the statement of
operations. If competitive pricing were to decrease sharply and unexpectedly, our estimates might
be insufficient, which could significantly adversely affect our operating results.
Additions to the ship and debit allowance are estimates of the amount of expected future ship
and debit activity related to sales during the period and reduce revenues and gross profit in the
period. The following table sets forth the beginning and ending balances of, additions to, and
deductions from, our allowance for ship and debit during the nine months ended December 31, 2009
(in thousands):
18
Table of Contents
Balance at March 31, 2009 |
$ | 414 | ||
Additions |
301 | |||
Deductions |
(353 | ) | ||
Balance at June 30, 2009 |
$ | 362 | ||
Additions |
634 | |||
Deductions |
(593 | ) | ||
Balance at September 30, 2009 |
$ | 403 | ||
Additions |
574 | |||
Deductions |
(556 | ) | ||
Balance at December 31, 2009 |
$ | 421 | ||
Allowance for doubtful accounts. We maintain an allowance for doubtful accounts for estimated
losses from the inability of our customers to make required payments. We evaluate our allowance for
doubtful accounts based on the aging of our accounts receivable, the financial condition of our
customers and their payment history, our historical write-off experience and other assumptions. If
we were to make different judgments of the financial condition of our customers or the financial
condition of our customers were to deteriorate, resulting in an impairment of their ability to make
payments, additional allowances may be required. This allowance is reported on the balance sheet as
part of the accounts receivable allowance and is included on the statement of operations as part of
selling, general and administrative expense. This allowance is based on historical losses and
managements estimates of future losses.
Inventories. Inventories are recorded at the lower of standard cost, which approximates actual
cost on a first-in-first-out basis, or market value. Our accounting for inventory costing is based
on the applicable expenditure incurred, directly or indirectly, in bringing the inventory to its
existing condition. Such expenditures include acquisition costs, production costs and other costs
incurred to bring the inventory to its use. As it is impractical to track inventory from the time
of purchase to the time of sale for the purpose of specifically identifying inventory cost, our
inventory is therefore valued based on a standard cost, given that the materials purchased are
identical and interchangeable at various production processes. The authoritative guidance provided
by FASB requires certain abnormal expenditures to be recognized as expenses in the current period
versus being capitalized in inventory. It also requires that the amount of fixed production
overhead allocated to inventory be based on the normal capacity of the production facilities. We
review our standard costs on an as-needed basis but in any event at least once a year, and update
them as appropriate to approximate actual costs.
We typically plan our production and inventory levels based on internal forecasts of customer
demand, which are highly unpredictable and can fluctuate substantially. The value of our
inventories is dependent on our estimate of future demand as it relates to historical sales. If our
projected demand is overestimated, we may be required to reduce the valuation of our inventories
below cost. We regularly review inventory quantities on hand and record an estimated provision for
excess inventory based primarily on our historical sales and expectations for future use. We also
recognize a reserve based on known technological obsolescence, when appropriate. However, for new
products, we do not consider whether there is excess inventory until we develop sufficient sales
history or experience a significant change in expected product demand, based on backlog. Actual
demand and market conditions may be different from those projected by our management. This could
have a material effect on our operating results and financial position. If we were to make
different judgments or utilize different estimates, the amount and timing of our write-down of
inventories could be materially different.
Excess inventory frequently remains saleable. When excess inventory is sold, it yields a gross
profit margin of up to 100%. Sales of excess inventory have the effect of increasing the gross
profit margin beyond that which would otherwise occur, because of previous write-downs. Once we
have written down inventory below cost, we do not subsequently write it up when it is subsequently
sold or scrapped. We do not physically segregate excess inventory nor do we assign unique tracking
numbers to it in our accounting systems. Consequently, we cannot isolate the sales prices of excess
inventory from the sales prices of non-excess inventory. Therefore, we are unable to report the
amount of gross profit resulting from the sale of excess inventory or quantify the favorable impact
of such gross profit on our gross profit margin.
The following table provides information on our excess and obsolete inventory reserve charged
against inventory at cost (in thousands):
19
Table of Contents
Balance at March 31, 2009 |
$ | 34,697 | ||
Sale of excess inventory |
(814 | ) | ||
Scrap of excess inventory |
(566 | ) | ||
Additional accrual of excess inventory |
4,458 | |||
Balance at June 30, 2009 |
$ | 37,775 | ||
Sale of excess inventory |
(719 | ) | ||
Scrap of excess inventory |
(495 | ) | ||
Additional accrual of excess inventory |
2,313 | |||
Balance at September 30, 2009 |
$ | 38,874 | ||
Sale of excess inventory |
(1,758 | ) | ||
Scrap of excess inventory |
(334 | ) | ||
Additional accrual of excess inventory |
1,262 | |||
Balance at December 31, 2009 |
$ | 38,044 | ||
The practical efficiencies of wafer fabrication require the manufacture of semiconductor
wafers in minimum lot sizes. Often, when manufactured, we do not know whether or when all the
semiconductors resulting from a lot of wafers will sell. With more than 10,000 different part
numbers for semiconductors, excess inventory resulting from the manufacture of some of those
semiconductors will be continual and ordinary. Because the cost of storage is minimal when compared
to potential value and because our products do not quickly become obsolete, we expect to hold
excess inventory for potential future sale for years. Consequently, we have no set time line for
the sale or scrapping of excess inventory.
In addition, our inventory is also being written down to the lower of cost or market or net
realizable value. We review our inventory listing on a quarterly basis for an indication of losses
being sustained for costs that exceed selling prices less direct costs to sell. When it is evident
that our selling price is lower than current cost, the inventory is marked down accordingly. At
December 31, 2009, our lower of cost or market reserve was $652,000.
Furthermore, we perform an annual inventory count and periodic cycle counts for specific parts
that have a high turnover. We also periodically identify any inventory that is no longer usable and
write it off.
Income tax. As part of the process of preparing our consolidated financial statements, we are
required to estimate our income taxes in each of the jurisdictions in which we operate. This
process involves estimating our actual current tax exposure together with assessing temporary
differences resulting from differing treatment of items for tax and accounting purposes. These
differences result in deferred tax assets and liabilities, which are included within our
consolidated balance sheet. We then assess the likelihood that our deferred tax assets will be
recovered from future taxable income and, to the extent we believe that recovery is not likely, we
establish a valuation allowance. A valuation allowance reduces our deferred tax assets to the
amount that is more likely than not to be realized. In determining the amount of the valuation
allowance, we consider estimated future taxable income as well as feasible tax planning strategies
in each taxing jurisdiction in which we operate. If we determine that it is more probable than not
that we will not realize all or a portion of our remaining deferred tax assets, then we will
increase our valuation allowance with a charge to income tax expense. Conversely, if we determine
that it is likely that we will ultimately be able to utilize all or a portion of the deferred tax
assets for which a valuation allowance has been provided, then the related portion of the valuation
allowance will reduce goodwill, intangible assets or income tax expense. Significant management
judgment is required in determining our provision for income taxes and potential tax exposures, our
deferred tax assets and liabilities and any valuation allowance recorded against our net deferred
tax assets. In the event that actual results differ from these estimates or we adjust these
estimates in future periods, we may need to establish a valuation allowance, which could materially
impact our financial position and results of operations. Our ability to utilize our deferred tax
assets and the need for a related valuation allowance are monitored on an ongoing basis.
Furthermore, computation of our tax liabilities involves examining uncertainties in the
application of complex tax regulations. We recognize liabilities for uncertain tax positions based
on the two-step process as prescribed. The first step is to evaluate the tax position for
recognition by determining if there is sufficient available evidence to indicate if it is more
likely than not that the position will be sustained on an audit, including resolution of any
related appeals or litigation processes. The second step requires us to measure and determine the
approximate amount of the tax benefit at the largest amount that is more than 50% likely of being
realized upon ultimate settlement with the tax authorities. It is inherently difficult and requires
significant judgment to estimate such amounts, as this requires us to determine the probability of
various possible outcomes. We reexamine these uncertain tax positions on a quarterly basis. This
reassessment is based on various factors during the period including, but not limited to, changes
in worldwide tax laws and treaties, changes in facts or circumstances, effectively settled issues
under audit and any new audit activity. A change in recognition or measurement would result in the
recognition of a tax benefit or an additional charge to the tax provision in the period.
20
Table of Contents
Recent Accounting Pronouncements
For a description of accounting changes and recent accounting pronouncements, including the
expected dates of adoption and estimated effects, if any, on our consolidated condensed financial
statements, see Note 2: Accounting Changes and Recent Accounting Pronouncements in the Notes to
Unaudited Condensed Consolidated Financial Statements of this Form 10-Q.
Results of Operations Three and Nine Months Ended December 31, 2009 and 2008
The following table sets forth selected consolidated statements of operations data for the
fiscal periods indicated and the percentage change in such data from period to period. These
historical operating results may not be indicative of the results for any future period.
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
2009 | % change | 2008 | 2009 | % change | 2008 | |||||||||||||||||||
(000) | (000) | (000) | (000) | |||||||||||||||||||||
Net revenues |
$ | 64,032 | 9.8 | % | $ | 58,337 | $ | 166,663 | -22.6 | % | $ | 215,308 | ||||||||||||
Cost of goods sold |
48,321 | 5.8 | % | 45,683 | 128,000 | -16.9 | % | 154,095 | ||||||||||||||||
Gross profit |
$ | 15,711 | 24.2 | % | $ | 12,654 | $ | 38,663 | -36.8 | % | $ | 61,213 | ||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Research, development and
engineering |
$ | 5,144 | 8.7 | % | $ | 4,733 | $ | 14,202 | -8.7 | % | $ | 15,558 | ||||||||||||
Selling, general and administrative |
8,817 | -4.3 | % | 9,209 | 25,183 | -18.0 | % | 30,701 | ||||||||||||||||
Restructuring charges |
32 | nm | | 1,042 | nm | | ||||||||||||||||||
Impairment charges |
| -100.0 | % | 3,749 | | -100.0 | % | 3,749 | ||||||||||||||||
Total operating expenses |
$ | 13,993 | -20.9 | % | $ | 17,691 | $ | 40,427 | -19.2 | % | $ | 50,008 | ||||||||||||
nm not meaningful |
The following table sets forth selected statements of operations data as a percentage of
net revenues for the fiscal periods indicated. These historical operating results may not be
indicative of the results for any future period.
% of Net Revenues | % of Net Revenues | |||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||
December 31, | December 31, | |||||||||||||||
2009 | 2008 | 2009 | 2008 | |||||||||||||
Net revenues |
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||
Cost of goods sold |
75.5 | % | 78.3 | % | 76.8 | % | 71.6 | % | ||||||||
Gross profit |
24.5 | % | 21.7 | % | 23.2 | % | 28.4 | % | ||||||||
Operating expenses: |
||||||||||||||||
Research, development and engineering |
8.0 | % | 8.1 | % | 8.5 | % | 7.2 | % | ||||||||
Selling, general and administrative |
13.8 | % | 15.8 | % | 15.1 | % | 14.3 | % | ||||||||
Restructuring charges |
0.0 | % | | 0.6 | % | | ||||||||||
Impairment charges |
| 6.4 | % | | 1.7 | % | ||||||||||
Total operating expenses |
21.8 | % | 30.3 | % | 24.2 | % | 23.2 | % | ||||||||
Operating income (loss) |
2.7 | % | -8.6 | % | -1.0 | % | 5.2 | % | ||||||||
Other income (expense), net |
0.6 | % | -0.5 | % | -1.6 | % | 0.6 | % | ||||||||
Income (loss) before income tax |
3.3 | % | -9.1 | % | -2.6 | % | 5.8 | % | ||||||||
(Provision for) benefit from income tax |
-2.7 | % | 2.3 | % | -0.2 | % | -2.3 | % | ||||||||
Net income (loss) |
0.6 | % | -6.8 | % | -2.8 | % | 3.5 | % | ||||||||
21
Table of Contents
Net Revenues.
The following tables set forth the revenues for each of our product groups for the fiscal
periods indicated:
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||||||||||
Revenues | 2009 | % change | 2008 | 2009 | % change | 2008 | ||||||||||||||||||
(000) | (000) | (000) | (000) | |||||||||||||||||||||
Power semiconductors |
$ | 43,662 | -3.7 | % | $ | 45,318 | $ | 122,999 | -27.9 | % | $ | 170,669 | ||||||||||||
Integrated circuits |
15,306 | 103.2 | % | 7,533 | 29,997 | 20.3 | % | 24,945 | ||||||||||||||||
Systems and RF
power semiconductors |
5,064 | -7.7 | % | 5,486 | 13,667 | -30.6 | % | 19,694 | ||||||||||||||||
Total |
$ | 64,032 | 9.8 | % | $ | 58,337 | $ | 166,663 | -22.6 | % | $ | 215,308 | ||||||||||||
The following tables set forth the average selling prices, or ASPs, and units for the
fiscal periods indicated:
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||||||||||
Average Selling Prices | 2009 | % change | 2008 | 2009 | % change | 2008 | ||||||||||||||||||
Power semiconductors |
$ | 2.38 | -7.4 | % | $ | 2.57 | $ | 2.39 | -11.2 | % | $ | 2.69 | ||||||||||||
Integrated circuits |
$ | 0.77 | 0.0 | % | $ | 0.77 | $ | 0.76 | 0.0 | % | $ | 0.76 | ||||||||||||
Systems and RF power
semiconductors |
$ | 24.00 | -7.3 | % | $ | 25.88 | $ | 21.73 | -15.5 | % | $ | 25.71 |
Three Months Ended December 31, | Nine Months Ended December 31, | |||||||||||||||||||||||
Units | 2009 | % change | 2008 | 2009 | % change | 2008 | ||||||||||||||||||
(000) | (000) | (000) | (000) | |||||||||||||||||||||
Power semiconductors |
18,338 | 4.0 | % | 17,633 | 51,533 | -18.8 | % | 63,496 | ||||||||||||||||
Integrated circuits |
19,926 | 104.1 | % | 9,763 | 39,674 | 21.1 | % | 32,759 | ||||||||||||||||
Systems and RF
power semiconductors |
211 | -0.5 | % | 212 | 629 | -17.9 | % | 766 | ||||||||||||||||
Total |
38,475 | 39.4 | % | 27,608 | 91,836 | -5.3 | % | 97,021 | ||||||||||||||||
The 9.8% increase in net revenues in the three months ended December 31, 2009 as compared
to the three months ended December 31, 2008 reflected a significant increase of $7.8 million, or
103.2%, in the sale of ICs, offset by a $1.7 million, or 3.7%, decrease in the sale of power
semiconductors and a $422,000, or 7.7%, decrease in the sale of systems and RF power
semiconductors. The increase in revenues from the sale of ICs was primarily driven by a $6.3
million increase in the sales of our display driver ICs to the consumer products markets as a
consequence of an acquisition. The decrease in power semiconductors was mainly due to a $1.6
million decrease in the sale of thyristor products, principally to the industrial and commercial
market. The decline in revenues from the sale of systems and RF power semiconductors was broad
based across all the major product lines.
For the three months ended December 31, 2009 as compared to the three months ended December
31, 2008, IC unit growth was principally due to increased shipments of display driver ICs to the
consumer products market, whereas in power semiconductors, the unit growth was primarily from
increases in MOS products sales. The unit shipments in systems and RF power semiconductors were
largely unchanged.
The 22.6% decline in net revenues in the nine months ended December 31, 2009 as compared to
the nine months ended December 31, 2008 reflected a $47.7 million, or 27.9% decrease in the sale of
power semiconductors and a $6.0 million, or 30.6%, decrease in the sale of systems and RF power
semiconductors, offset by an increase of $5.0 million, or 20.3%, in the sale of ICs. The decrease
in power semiconductors was broad based in all the major product lines, including a $20.0 million
decline in the sale of thyristor products, principally to the industrial and commercial market. The
revenues from the sale of systems and RF power semiconductors decreased primarily due to a decrease
of $4.9 million in the sale of subassemblies to the industrial and commercial market. The
increase in revenues from ICs was principally due to a $7.2 million increase in the sale of
display driver ICs, to the consumer products markets, offset by decrease in the sale of solid state
relays, or SSRs, of $2.4 million, primarily to the consumer product market.
For the nine months ended December 31, 2009 as compared to the nine months ended December 31,
2008, the decline in shipments of power semiconductors was due to reduced shipments of bipolar
products, principally to the industrial and commercial market. In systems and RF power
22
Table of Contents
semiconductors, the unit decline was principally caused by reduced shipments of RF power
semiconductors. In ICs, the unit growth was because of increased shipments of display driver ICs to
the consumer market, offset by a decrease in the sale of SSRs.
For the three and nine months ended December 31, 2009 as compared to the comparable periods of
the previous fiscal year, the decrease in the ASPs of power semiconductor and system and RF power
semiconductors was due to a change in the mix of products sold; whereas, the ASPs of ICs were
unchanged.
For the quarter ended December 31, 2009, sales to customers in the United States represented
approximately 27.0% of our net revenues and sales to international customers represented
approximately 73.0% of our net revenues. Of our international sales, approximately 45.3% were
derived from sales in Europe and the Middle East, approximately 48.9% were derived from sales in
the Asia Pacific region and approximately 5.8% were derived from sales in the rest of the world. By
comparison, for the quarter ended December 31, 2008, sales to customers in the United States
represented approximately 30.0% of our net revenues and sales to international customers
represented approximately 70.0% of our net revenues. Of our international sales, approximately
55.6% were derived from sales in Europe and the Middle East, approximately 35.0% were derived from
sales in the Asia Pacific region and approximately 9.4% were derived from sales in the rest of the
world.
For the three months ended December 31, 2009 as compared to the three months ended December
31, 2008, we experienced substantial growth in sales in China, primarily to the consumer product
market, offset by declines in revenues across all the major European countries, except the United
Kingdom and Sweden, and in the U.S. and India. The decline in revenues in the European countries
was primarily due to the decline in revenues from the industrial and commercial market. The decline
in revenues in the U.S. and India was due to reduced shipments of thyristor products to the
industrial and commercial market.
For the nine months ended December 31, 2009, sales to customers in the United States
represented approximately 29.8% of our net revenues and sales to international customers
represented approximately 70.2% of our net revenues. Of our international sales, approximately
47.3% were derived from sales in Europe and the Middle East, approximately 46.0% were derived from
sales in the Asia Pacific region and approximately 6.7% were derived from sales in the rest of the
world. By comparison, for the nine months ended December 31, 2008, sales to customers in the United
States represented approximately 28.1% of our net revenues and sales to international customers
represented approximately 71.9% of our net revenues. Of our international sales, approximately
57.5% were derived from sales in Europe and the Middle East, approximately 33.4% were derived from
sales in the Asia Pacific region and approximately 9.1% were derived from sales in the rest of the
world.
For the nine months ended December 31, 2009 as compared to the nine months ended December 31,
2008, our sales in China increased primarily to the consumer market, offset by substantial declines
in revenues across all the major European countries and in the U.S. and India. The decline in the
European countries was primarily due to reduced revenues from the industrial and commercial market.
The decline in the U.S. was primarily due to the decrease in revenues from the medical market and
the industrial and commercial market; whereas, the decline in revenues in India was due to lower
shipments of thyristor products to the industrial and commercial market.
For the three and nine months ended December 31, 2009, one customer accounted for 10.4% and
11.3%, respectively, of our net revenues. For the three and nine months ended December 31, 2008, no
customer accounted for more than 10% of our net revenues.
Our revenues were reduced by allowances for sales returns, stock rotations and ship and debit.
See Critical Accounting Policies and Significant Management Estimates elsewhere in this
Managements Discussion and Analysis of Financial Condition and Results of Operations.
Gross Profit.
Gross profit margin increased to 24.5% in the three months ended December 31, 2009 from 21.7%
in the three months ended December 31, 2008. The gross profit margin increase was primarily a
result of a $3.5 million reduction in inventory write-downs in the quarter ended December 31, 2009
as compared to the quarter ended December 31, 2008.
For the nine months ended December 31, 2009, the gross profit margin decreased to 23.2%, as
compared to 28.4% for the nine months ended December 31, 2008. The decline in the gross profit
margin was principally due to underutilized capacity caused by decreased revenues as a result of
the global economic downturn.
Research, Development and Engineering.
R&D expenses typically consist of internal engineering efforts for product design and
development. As a percentage of net revenues, our R&D expenses for the three and nine months ended
December 31, 2009 were 8.0% and 8.5%, respectively, as compared to 8.1% and 7.2% for the three and
nine months ended December 31, 2008. The increase in the percentage of R&D expenses for the
23
Table of Contents
nine
months ended December 31, 2009 was due to a decrease in net revenues, rather than an increase in
R&D expenses. Expressed in absolute dollars, for the three months ended December 31, 2009 as
compared to the same period of the prior year, our R&D expenses increased by approximately
$411,000, or 8.7%. The acquisition of our display driver business in the quarter ended September
30, 2009 resulted in an increase in R&D headcount and expenses in the quarter ended December 31,
2009. For the nine months ended December 31, 2009 as compared to the same period of the prior year,
our R&D expenses decreased by approximately $1.4 million, or 8.7%. The decreases in R&D expenses
were mainly due to a reduction in personnel costs related to plant shutdowns.
Selling, General and Administrative.
As a percentage of net revenues, our SG&A expenses for the three and nine months ended
December 31, 2009 were 13.8% and 15.1%, respectively, as compared to 15.8% and 14.3% for the three
and nine months ended December 31, 2008. Expressed in absolute dollars, SG&A expenses declined by
$392,000 and $5.5 million, or 4.3% and 18.0%, respectively, for the three and nine months ended
December 31, 2009 as compared to the same periods in the prior year, primarily due to lower sales
and marketing expenses caused by lower commission expense, as well as lower personnel costs and
freight expense.
Restructuring Charges.
In the quarter ended September 30, 2009, we initiated plans to restructure our European
manufacturing and assembly operations to align them to current market conditions. The plans
primarily involved the termination of employees and centralization of certain positions. Costs
related to termination of employees represented severance payments and benefits. The restructuring
charges recorded in conjunction with the plan represented severance costs and have been included
under Restructuring charges in our unaudited condensed consolidated statements of operations. The
restructuring accrual as of December 31, 2009 was included under Accrued expenses and other
current liabilities on our unaudited condensed consolidated balance sheets.
During the three and nine months ended December 31, 2009, we incurred restructuring charges of
$32,000 and $1.0 million, respectively. See Note 4: Restructuring Charges in the Notes to
Unaudited Condensed Consolidated Financial Statements of this Form 10-Q.
Other Income (Expense), net.
In the quarter ended December 31, 2009, other income, net was $691,000 as compared to other
expense, net of $109,000 in the quarter ended December 31, 2008. The other income, net in the three
months ended December 31, 2009 principally consisted of $682,000 of gains associated with changes
in exchange rates for foreign currency transactions. The other expense, net in the three months
ended December 31, 2008 consisted principally of losses associated with changes in exchange rates
for foreign currency transactions.
Other expense, net in the nine months ended December 31, 2009 was $1.7 million, as compared to
other income, net of $1.6 million in the nine months ended December 31, 2008. For the nine months
ended December 31, 2009, other expense, net consisted principally of losses associated with changes
in exchange rates for foreign currency transactions of $1.6 million. For the nine months ended
December 31, 2008, other income, net primarily consisted of gains associated with changes in
exchange rates for foreign currency transactions.
Provision for Income Tax.
For the three and nine months ended December 31, 2009, we recorded income tax provisions of
$1.7 million and $347,000. For the three and nine months ended December 31, 2008, we recorded
income tax benefit of $1.3 million and an income tax provision of $4.9 million, respectively. For
the three months ended December 31, 2009, the provision for income tax represented the adjustment
of the income tax account to reflect a change in our estimated income taxes for the year based on
nine months of experience, offset by a favorable impact on the reversal of accrued tax expenses of
$350,000 following the conclusion of an audit in a foreign tax jurisdiction. The provision for
income tax for the nine months ended December 31, 2009 was incurred because we had profits in
certain jurisdictions and losses in jurisdictions with comparatively lower tax rates, partially
offset by the release of valuation allowances. For the three and nine months ended December 31,
2008, our accounting for income tax was affected by permanent items, including the goodwill
impairment, net of a valuation allowance release.
Liquidity and Capital Resources
At December 31, 2009, cash and cash equivalents were $86.5 million as compared to $55.4
million at March 31, 2009.
Our cash provided by operating activities for the nine months ended December 31, 2009 was
$23.2 million, an increase of $6.1 million as compared to the comparable period of the prior year.
Our operating cash flow improved in large part as a result of reduced
24
Table of Contents
inventory purchasing. Our net
inventories decreased by $10.2 million, or 13.5%, as compared to net inventories at March 31, 2009,
primarily due to reduced inventory purchases and higher inventory reserves. Accounts receivable at
December 31, 2009 decreased by $709,000, or 1.9%, as compared to the accounts receivable at March
31, 2009, primarily due to the reduction in net revenues for the nine months ended December 31,
2009. Our accounts payable at December 31, 2009 increased by $2.9 million, or 21.2%, from accounts
payable at March 31, 2009, primarily because of the timing of the purchase of inventory.
Our net cash used in investing activities for the nine months ended December 31, 2009 was $5.4
million as compared to net cash used in investing activities of $4.9 million during the nine months
ended December 31, 2008. During the nine months ended December 31, 2009, our uses of cash for
investing activities principally reflected $2.6 million for a business combination and $2.6 million
in purchases of property and equipment. During the nine months ended December 31, 2008, we spent
$7.8 million on purchases of property, plant and equipment, which was offset by proceeds of $3.9
million from sales of investments and assets.
For the nine months ended December 31, 2009, net cash received in financing activities was
$11.5 million, as compared to net cash used in financing activities of $12.4 million in the nine
months ended December 31, 2008. During the nine months ended December 31, 2009, net cash provided
by financing activities primarily reflected $15.0 million in proceeds borrowed under line of
credit, offset by $4.2 million in principal payments on capital lease and loan obligations. During
the nine months ended December 31, 2008, net cash was used primarily for principal repayments on
capital lease obligations and repayments of loans, offset by proceeds from employee equity plans.
At December 31, 2009, capital lease obligations and loans payable totaled $39.6 million. This
represented 45.7% of our cash and cash equivalents and 21.6% of our stockholders equity.
We are obligated on a 7.0 million, or $10.0 million, loan. The loan has a remaining term
of about 11 years, ending in June 2020, and bears a variable interest rate, dependent upon the
current Euribor rate and the ratio of indebtedness to cash flow for the German subsidiary. Each
fiscal quarter a principal payment of 167,000, or about $239,000, and a payment of accrued
interest are required. Financial covenants for a ratio of indebtedness to cash flow, a ratio of
equity to total assets and a minimum stockholders equity for the German subsidiary must be
satisfied for the loan to remain in good standing. The loan may be prepaid in whole or in part at
the end of a fiscal quarter without penalty. At December 31, 2009, we complied with the financial
covenants. The loan is collateralized by a security interest in the facility in Lampertheim,
Germany, which is owned by our U.S. parent.
On August 2, 2007, we completed the purchase of a building in Milpitas, California. We moved
our corporate office and a facility for operations to this location in January 2008. In connection
with the purchase, we assumed a loan, secured by the building, of $7.5 million. The loan bears
interest at the rate of 7.455% per annum and is due and payable in February 2011. Monthly payments
of principal and interest of $56,000 are due under the loan. In addition, monthly impound payments
aggregating $14,000 are to be made for items such as real property taxes, insurance and capital
expenditures. The balance of the loan liability at December 31, 2009 was $7.2 million. At maturity,
the remaining balance on the loan will be approximately $7.1 million.
In September 2009, we entered into an agreement with Bank of the West, or BOW, for a letter of
credit facility of $3.0 million. The facility expires on March 31, 2010. At December 31, 2009,
there was an open letter of credit with a balance of $52,000 to support inventory purchases.
On November 13, 2009, we entered into a credit agreement for a revolving line of credit with
BOW, under which we may borrow up to $15.0 million. Borrowings may be repaid and re-borrowed during
the term of the credit agreement. The obligations are guaranteed by two of our subsidiaries. All
amounts owed under the credit agreement are due and payable on October 31, 2011. On November 16,
2009, we borrowed $15.0 million pursuant to the credit agreement. See Note 9, Borrowing
Arrangements in the Notes to Unaudited Condensed Consolidated Financial Statements of this Form
10-Q for further information regarding the credit agreement.
The Agreement also includes a $3.0 million letter of credit subfacility commencing in April
2010. See Note 16, Commitment and Contingencies in the Notes to Unaudited Condensed Consolidated
Financial Statements of this Form 10-Q for further information regarding the terms of the
subfacility.
On December 5, 2009, we entered into a definitive agreement to acquire Zilog, Inc., or Zilog.
Under the terms of the agreement, we will acquire all of the Zilogs outstanding common shares for
$3.5858 per share in cash and cash out its outstanding stock options for
aggregate consideration of approximately $62.4 million. The acquisition is subject to the
approval of Zilog shareholders and other customary closing conditions. The transaction is expected
to be completed during the quarter ended March 31, 2010.
Additionally, we maintain two defined benefit pension plans: one for the United Kingdom
employees and one for German employees. These plans cover most of the employees in the United
Kingdom and Germany. Benefits are based on years of service and the employees compensation. We
deposit funds for these plans, consistent with the requirements of local law, with investment
25
Table of Contents
management companies, insurance companies, trustees or accrue for the unfunded portion of the
obligations. Both plans have been curtailed. As such, the plans are closed to new entrants and no
credit is provided for additional periods of service. The total pension liability accrued for these
plans at December 31, 2009 was $14.4 million.
We believe that our cash and cash equivalents, together with cash generated from operations,
will be sufficient to meet our anticipated cash requirements for the next 12 months. Our liquidity
could be negatively affected by a decline in demand for our products, increases in the cost of
materials or labor, investments in new product development or one or more acquisitions. We use
derivative contracts in the normal course of business to manage our foreign currency exchange and
interest rate risks. We did not have any significant open derivative contracts at December 31,
2009. There can be no assurance that additional debt or equity financing will be available when
required or, if available, can be secured on terms satisfactory to us.
26
Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Our market risk has not changed materially from the market risk disclosed in Item 7A,
Quantitative and Qualitative Disclosures About Market Risk, of our Annual Report on Form 10-K for
the fiscal year ended March 31, 2009.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
Based on their evaluation as of December 31, 2009, our Chief Executive Officer and Chief
Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules
13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) were effective to
ensure that the information required to be disclosed by us in this Quarterly Report on Form 10-Q
was recorded, processed, summarized and reported within the time periods specified in the SECs
rules and regulations. Furthermore, these controls and procedures were also effective to ensure
that information required to be disclosed by us in this Quarterly Report on Form 10-Q was
accumulated and communicated to our management, including our Chief Executive Officer and Chief
Financial Officer, to allow timely decisions regarding required disclosure.
Inherent Limitations on Effectiveness of Controls
Our management, including our Chief Executive Officer and Chief Financial Officer, does not
expect that our procedures or our internal controls will prevent or detect all errors and all
fraud. An internal control system, no matter how well conceived and operated, can provide only
reasonable, not absolute, assurance that the objectives of the control system are met. Because of
the inherent limitations in all control systems, no evaluation of our controls can provide absolute
assurance that all control issues, errors and instances of fraud, if any, have been detected.
27
Table of Contents
PART II OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We currently are involved in a variety of legal matters that arise in the normal course of
business. Based on information currently available, management does not believe that the ultimate
resolution of these matters will have a material adverse effect on our financial condition, results
of operations and cash flows. Were an unfavorable ruling to occur, there exists the possibility of
a material adverse impact on the results of operations of the period in which the ruling occurs.
ITEM 1A. RISK FACTORS
In addition to the other information in this Quarterly Report on Form 10-Q, the following risk
factors should be considered carefully in evaluating our business and us. Additional risks not
presently known to us or that we currently believe are not serious may also impair our business and
its financial condition.
Fluctuations in demand for our products may harm our financial results and are difficult to
forecast.
Current uncertainty in global economic conditions poses a risk to the overall economy and to
our business, as our customers may defer purchases in response to tighter credit and negative
financial news, which could negatively affect product demand and other related matters. If demand
for our products fluctuates as a result of economic conditions or otherwise, our revenues and gross
margin could be harmed. Important factors that could cause demand for our products to fluctuate
include:
| changes in business and economic conditions, including a downturn in the semiconductor industry and/or the overall economy; | ||
| changes in consumer and business confidence caused by changes in market conditions, including changes in the credit market, expectations for inflation, and energy prices; | ||
| competitive pressures, particularly pricing pressures; | ||
| changes in customer product needs; | ||
| changes in the level of customers components inventory; and | ||
| strategic actions taken by our competitors. |
If product demand decreases, our manufacturing or assembly and test capacity could be
underutilized, and we may be required to record an impairment on our long-lived assets including
facilities and equipment, as well as intangible assets, which would increase our expenses. In
addition, factory planning decisions may shorten the useful lives of long-lived assets, including
facilities and equipment, and cause us to accelerate depreciation. These changes in demand for our
products and in our customers product needs could have a variety of negative effects on our
competitive position and our financial results and, in certain cases, may reduce our revenues,
increase our costs, lower our gross margin percentage or require us to recognize impairments of our
assets. In addition, if product demand decreases or we fail to forecast demand accurately, we could
be required to write off inventory or record underutilization charges, which would have a negative
impact on our gross margin.
Our visibility regarding the future has declined.
As economic uncertainty has increased, our customers have reduced their advance orders and
issued orders with shorter lead times. This has reduced our visibility regarding future production
and shipments, and related revenues. With such reduced visibility, our understanding regarding the
direction and rate of change in our product markets has declined and the risks attendant to
decisions based on estimates of future orders and shipments, such as the ordering of raw materials,
the commencement of production and the appropriate levels of inventory, have increased.
The recent financial crisis could negatively affect our business, results of operations and
financial condition.
The recent financial crisis affecting the banking system and financial markets have resulted
in a tightening in the credit markets and low level of liquidity for many companies. There could be
a number of effects from the credit crisis on our business, including insolvency of key suppliers
resulting in product delays and inability of customers to obtain credit to finance purchases of our
products and/or customer insolvencies.
28
Table of Contents
Our operating results fluctuate significantly because of a number of factors, many of which
are beyond our control.
Given the nature of the markets in which we participate, we cannot reliably predict future
revenues and profitability, and unexpected changes may cause us to adjust our operations. Large
portions of our costs are fixed, due in part to our significant sales, research and development and
manufacturing costs. Thus, small declines in revenues could seriously negatively affect our
operating results in any given quarter. Our operating results may fluctuate significantly from
quarter to quarter and year to year. For example, comparing fiscal 2002 to fiscal 2001, net
revenues fell by 25.6% and net income fell by 85.7%. Further, from fiscal 2005 to fiscal 2006 and
from fiscal 2008 to fiscal 2009, net income in one year shifted to net loss in the next year. Some
of the factors that may affect our quarterly and annual results are:
| the reduction, rescheduling or cancellation of orders by customers; | ||
| fluctuations in timing and amount of customer requests for product shipments; | ||
| changes in the mix of products that our customers purchase; | ||
| loss of key customers; | ||
| the cyclical nature of the semiconductor industry; | ||
| competitive pressures on selling prices; | ||
| damage awards or injunctions as the result of litigation; | ||
| market acceptance of our products and the products of our customers; | ||
| fluctuations in our manufacturing yields and significant yield losses; | ||
| difficulties in forecasting demand for our products and the planning and managing of inventory levels; | ||
| the availability of production capacity; | ||
| the amount and timing of investments in research and development; | ||
| changes in our product distribution channels and the timeliness of receipt of distributor resale information; | ||
| the impact of vacation schedules and holidays, largely during the second and third fiscal quarters of our fiscal year; and | ||
| the amount and timing of costs associated with product returns. |
As a result of these factors, many of which are difficult to control or predict, as well as
the other risk factors discussed in this Quarterly Report on Form 10-Q, we may experience
materially adverse fluctuations in our future operating results on a quarterly or annual basis.
Our gross margin is dependent on a number of factors, including our level of capacity utilization.
Semiconductor manufacturing requires significant capital investment leading to high fixed
costs including depreciation expense. We are limited in our ability to reduce fixed costs quickly
in response to any shortfall in revenues. If we are unable to utilize our manufacturing, assembly
and testing facilities at a high level, the fixed costs associated with these facilities will not
be fully absorbed, resulting in lower gross margins. Increased competition and other factors may
lead to price erosion, lower revenues and lower gross margins for us in the future.
We order materials and commence production in advance of anticipated customer demand. Therefore,
revenue shortfalls may also result in inventory write-downs.
We typically plan our production and inventory levels based on our own expectations for
customer demand. Actual customer demand, however, can be highly unpredictable and can fluctuate
significantly. In response to anticipated long lead times to obtain inventory and materials, we
order materials and production in advance of customer demand. This advance ordering and production
may result in excess inventory levels or unanticipated inventory write-downs if expected orders
fail to materialize. This risk has
29
Table of Contents
increased in recent periods, as economic conditions have declined. For example, additional
inventory write-downs occurred in the quarter ended March 31, 2009.
Our backlog may not result in future revenues.
Customer orders typically can be cancelled or rescheduled without penalty to the customer. As
a result, our backlog at any particular date is not necessarily indicative of actual revenues for
any succeeding period. A reduction of backlog during any particular period, or the failure of our
backlog to result in future revenues, could harm our results of operations.
Our international operations expose us to material risks.
For the nine months ended December 31, 2009, our product sales by region were approximately
29.8% in the United States, approximately 33.2% in Europe and the Middle East, approximately 32.3%
in Asia Pacific and approximately 4.7% in Canada and the rest of the world. We expect revenues from
foreign markets to continue to represent a significant portion of total revenues. We maintain
significant operations in Germany and the United Kingdom and contracts with suppliers and
manufacturers in South Korea, Japan and elsewhere in Europe and Asia Pacific. Some of the risks
inherent in doing business internationally are:
| foreign currency fluctuations; | ||
| longer payment cycles; | ||
| challenges in collecting accounts receivable; | ||
| changes in the laws, regulations or policies of the countries in which we manufacture or sell our products; | ||
| trade restrictions; | ||
| cultural and language differences; | ||
| employment regulations; | ||
| limited infrastructure in emerging markets; | ||
| transportation delays; | ||
| seasonal reduction in business activities; | ||
| work stoppages; | ||
| labor and union disputes; | ||
| terrorist attack or war; and | ||
| economic or political instability. |
Our sales of products manufactured in our Lampertheim, Germany facility and our costs at that
facility are primarily denominated in Euros, and sales of products manufactured in our Chippenham,
U.K. facility and our costs at that facility are primarily denominated in British pounds.
Fluctuations in the value of the Euro and the British pound against the U.S. dollar could have a
significant adverse impact on our balance sheet and results of operations. We generally do not
enter into foreign currency hedging transactions to control or minimize these risks. Fluctuations
in currency exchange rates could cause our products to become more expensive to customers in a
particular country, leading to a reduction in sales or profitability in that country. If we expand
our international operations or change our pricing practices to denominate prices in other foreign
currencies, we could be exposed to even greater risks of currency fluctuations.
In addition, the laws of certain foreign countries may not protect our products or
intellectual property rights to the same extent as do U.S. laws regarding the manufacture and sale
of our products in the U.S. Therefore, the risk of piracy of our technology and products may be
greater when we manufacture or sell our products in these foreign countries.
The semiconductor industry is cyclical, and an industry downturn could adversely affect our
operating results.
Business conditions in the semiconductor industry may rapidly change from periods of strong
demand and insufficient production to periods of weakened demand and overcapacity. The industry in
general is characterized by:
30
Table of Contents
| changes in product mix in response to changes in demand; | ||
| alternating periods of overcapacity and production shortages, including shortages of raw materials; | ||
| cyclical demand for semiconductors; | ||
| significant price erosion; | ||
| variations in manufacturing costs and yields; | ||
| rapid technological change and the introduction of new products; and | ||
| significant expenditures for capital equipment and product development. |
These factors could harm our business and cause our operating results to suffer.
Fluctuations in the mix of products sold may adversely affect our financial results.
Changes in the mix and types of products sold may have a substantial impact on our revenues
and gross profit margins. In addition, more recently introduced products tend to have higher
associated costs because of initial overall development costs and higher start-up costs.
Fluctuations in the mix and types of our products may also affect the extent to which we are able
to recover our fixed costs and investments that are associated with a particular product, and as a
result can negatively impact our financial results.
Our dependence on subcontractors to assemble and test our products subjects us to a number of
risks, including an inadequate supply of products and higher materials costs.
We depend on subcontractors for the assembly and testing of our products. The substantial
majority of our products are assembled by subcontractors located outside of the United States. Our
reliance on these subcontractors involves the following significant risks:
| bankruptcy or insolvency of one or more of our subcontractors adversely affecting our production; | ||
| reduced control over delivery schedules and quality; | ||
| lack of adequate capacity during periods of excess demand; | ||
| difficulties selecting and integrating new subcontractors; | ||
| limited or no warranties by subcontractors or other vendors on products supplied to us; | ||
| increases in prices due to capacity shortages and other factors; | ||
| misappropriation of our intellectual property; and | ||
| economic or political instability in foreign countries. |
These risks may lead to delayed product delivery or increased costs, which would harm our
profitability and customer relationships.
In addition, we use a limited number of subcontractors to assemble a significant portion of
our products. If one or more of these subcontractors experience financial, operational, production
or quality assurance difficulties, we could experience a reduction or interruption in supply. For
example, two of our recent assembly subcontractors have either ceased operations or entered into
insolvency proceedings. Although we believe alternative subcontractors are available, our operating
results could temporarily suffer until we engage one or more of those alternative subcontractors.
Moreover, in engaging alternative subcontractors in exigent circumstances, our production costs
could increase markedly.
Changes in our decisions about restructuring could affect our results of operations and financial
condition.
Factors that could cause actual results to differ materially from our expectations about
restructuring actions include:
| timing and execution of a plan that may be subject to local labor law requirements, including consultation with appropriate work councils; |
31
Table of Contents
| changes in assumptions related to severance costs; | ||
| changes in employment levels and turnover rates; and | ||
| changes in product demand and the business environment, including changes in global economic conditions. |
Semiconductors for inclusion in consumer products have short product life cycles.
We believe that consumer products are subject to shorter product life cycles, because of
technological change, consumer preferences, trendiness and other factors, than other types of
products sold by our customers. Shorter product life cycles result in more frequent design
competitions for the inclusion of semiconductors in next generation consumer products, which may
not result in design wins for us.
We may not be successful in our acquisitions.
We have in the past made, and may in the future make, acquisitions of other companies and
technologies. These acquisitions involve numerous risks, including:
| diversion of managements attention during the acquisition process; | ||
| disruption of our ongoing business; | ||
| the potential strain on our financial and managerial controls and reporting systems and procedures; | ||
| unanticipated expenses and potential delays related to integration of an acquired business; | ||
| the risk that we will be unable to develop or exploit acquired technologies; | ||
| failure to successfully integrate the operations of an acquired company with our own; | ||
| the challenges in achieving strategic objectives, cost savings and other benefits from acquisitions; | ||
| the risk that our markets do not evolve as anticipated and that the technologies acquired do not prove to be those needed to be successful in those markets; | ||
| the risks of entering new markets in which we have limited experience; | ||
| difficulties in expanding our information technology systems or integrating disparate information technology systems to accommodate the acquired businesses; | ||
| failure to retain key personnel of the acquired business; | ||
| the challenges inherent in managing an increased number of employees and facilities and the need to implement appropriate policies, benefits and compliance programs; | ||
| customer dissatisfaction or performance problems with an acquired companys products or personnel; | ||
| adverse effects on our relationships with suppliers; | ||
| the reduction in financial stability associated with the incurrence of debt or the use of a substantial portion of our available cash; | ||
| the costs associated with acquisitions, including in-process R&D charges and amortization expense related to intangible assets, and the integration of acquired operations; and | ||
| assumption of known or unknown liabilities or other unanticipated events or circumstances. |
We cannot assure that we will be able to successfully acquire other businesses or product
lines or integrate them into our operations without substantial expense, delay in implementation or
other operational or financial problems.
32
Table of Contents
As a result of an acquisition, our financial results may differ from the investment
communitys expectations in a given quarter. Further, if market conditions or other factors lead us
to change our strategic direction, we may not realize the expected value from such transactions. If
we do not realize the expected benefits or synergies of such transactions, our consolidated
financial position, results of operations, cash flows, or stock price could be negatively impacted.
We depend on external foundries to manufacture many of our products.
Of our revenues for nine months ended December 31, 2009, 37.7% came from wafers manufactured
for us by external foundries. Our dependence on external foundries may grow. We currently have
arrangements with a number of wafer foundries, three of which produce the wafers for power
semiconductors that we purchase from external foundries. Samsung Electronics facility in Kiheung,
South Korea is our principal external foundry.
Our relationships with our external foundries do not guarantee prices, delivery or lead times
or wafer or product quantities sufficient to satisfy current or expected demand. These foundries
manufacture our products on a purchase order basis. We provide these foundries with rolling
forecasts of our production requirements. However, the ability of each foundry to provide wafers to
us is limited by the foundrys available capacity. At any given time, these foundries could choose
to prioritize capacity for their own use or other customers or reduce or eliminate deliveries to us
on short notice. If growth in demand for our products occurs, these foundries may be unable or
unwilling to allocate additional capacity to our needs, thereby limiting our revenue growth.
Accordingly, we cannot be certain that these foundries will allocate sufficient capacity to satisfy
our requirements. In addition, we cannot be certain that we will continue to do business with these
or other foundries on terms as favorable as our current terms. If we are not able to obtain foundry
capacity as required, our relationships with our customers could be harmed, we could be unable to
fulfill contractual requirements and our revenues could be reduced or growth limited. Moreover,
even if we are able to secure foundry capacity, we may be required, either contractually or as a
practical business matter, to utilize all of that capacity or incur penalties or an adverse effect
on the business relationship. The costs related to maintaining foundry capacity could be expensive
and could harm our operating results. Other risks associated with our reliance on external
foundries include:
| the lack of control over delivery schedules; | ||
| the unavailability of, or delays in obtaining access to, key process technologies; | ||
| limited control over quality assurance, manufacturing yields and production costs; and | ||
| potential misappropriation of our intellectual property. |
Our requirements typically represent a small portion of the total production of the external
foundries that manufacture our wafers and products. We cannot be certain these external foundries
will continue to devote resources to the production of our wafers and products or continue to
advance the process design technologies on which the manufacturing of our products is based. These
circumstances could harm our ability to deliver our products or increase our costs.
Our success depends on our ability to manufacture our products efficiently.
We manufacture our products in facilities that are owned and operated by us, as well as in
external wafer foundries and subcontract assembly facilities. The fabrication of semiconductors is
a highly complex and precise process, and a substantial percentage of wafers could be rejected or
numerous die on each wafer could be nonfunctional as a result of, among other factors:
| contaminants in the manufacturing environment; | ||
| defects in the masks used to print circuits on a wafer; | ||
| manufacturing equipment failure; or | ||
| wafer breakage. |
For these and other reasons, we could experience a decrease in manufacturing yields.
Additionally, if we increase our manufacturing output, we may also experience a decrease in
manufacturing yields. As a result, we may not be able to cost-effectively expand our production
capacity in a timely manner.
33
Table of Contents
Our debt agreements contain certain restrictions that may limit our ability to operate
our business.
The agreements governing our debt contain, and any other future debt agreement we enter into
may contain, restrictive covenants that limit our ability to operate our business, including, in
each case subject to certain exceptions, restrictions on our ability to:
| incur additional indebtedness; | ||
| grant liens; | ||
| consolidate, merge or sell assets as an entirety or substantially as an entirety unless specified conditions are met; | ||
| acquire other business organizations; | ||
| make investments; | ||
| redeem or repurchase our stock; and | ||
| change the nature of our business. |
In addition, our debt agreements contain financial covenants and additional affirmative and
negative covenants. Our ability to comply with these covenants is dependent on our future
performance, which will be subject to many factors, some of which are beyond our control, including
prevailing economic conditions. If we are not able to comply with all of these covenants for any
reason and we have debt outstanding at the time of such failure, some or all of our outstanding
debt could become immediately due and payable and the incurrence of additional debt under the
credit facilities provided by the debt agreements would not be allowed. If our cash is utilized to
repay any outstanding debt, depending on the amount of debt outstanding, we could experience an
immediate and significant reduction in working capital available to operate our business.
As a result of these covenants, our ability to respond to changes in business and economic
conditions and to obtain additional financing, if needed, may be significantly restricted, and we
may be prevented from engaging in transactions that might otherwise be beneficial to us, such as
strategic acquisitions or joint ventures.
Increasing raw material prices could impact our profitability.
Our products use large amounts of silicon, metals and other materials. In recent periods, we
have experienced price increases for many of these items. If we are unable to pass price increases
for raw materials onto our customers, our gross margins and profitability could be adversely
affected.
Our markets are subject to technological change and our success depends on our ability to develop
and introduce new products.
The markets for our products are characterized by:
| changing technologies; | ||
| changing customer needs; | ||
| frequent new product introductions and enhancements; | ||
| increased integration with other functions; and | ||
| product obsolescence. |
To develop new products for our target markets, we must develop, gain access to and use
leading technologies in a cost-effective and timely manner and continue to expand our technical and
design expertise. Failure to do so could cause us to lose our competitive position and seriously
impact our future revenues.
Products or technologies developed by others may render our products or technologies obsolete
or noncompetitive. A fundamental shift in technologies in our product markets would have a material
adverse effect on our competitive position within the industry.
34
Table of Contents
Our revenues are dependent upon our products being designed into our customers products.
Many of our products are incorporated into customers products or systems at the design stage.
The value of any design win largely depends upon the customers decision to manufacture the
designed product in production quantities, the commercial success of the customers product and the
extent to which the design of the customers electronic system also accommodates incorporation of
components manufactured by our competitors. In addition, our customers could subsequently redesign
their products or systems so that they no longer require our products. The development of the next
generation of products by our customers generally results in new design competitions for
semiconductors, which may not result in design wins for us, potentially leading to reduced revenues
and profitability. We may not achieve design wins or our design wins may not result in future
revenues.
We could be harmed by intellectual property litigation.
As a general matter, the semiconductor industry is characterized by substantial litigation
regarding patent and other intellectual property rights. We have been sued on occasion for
purported patent infringement. In the future, we could be accused of infringing the intellectual
property rights of third parties. We also have certain indemnification obligations to customers and
suppliers with respect to the infringement of third party intellectual property rights by our
products. We could incur substantial costs defending ourselves and our customers and suppliers from
any such claim. Infringement claims or claims for indemnification, whether or not proven to be
true, may divert the efforts and attention of our management and technical personnel from our core
business operations and could otherwise harm our business. For example, in June 2000, we were sued
for patent infringement by International Rectifier Corporation. The case was ultimately resolved in
our favor, but not until October 2008. In the interim, the U.S. District Court entered multimillion
dollar judgments against us on two different occasions, each of which was subsequently vacated.
In the event of an adverse outcome in any intellectual property litigation, we could be
required to pay substantial damages, cease the development, manufacturing, use and sale of
infringing products, discontinue the use of certain processes or obtain a license from the third
party claiming infringement with royalty payment obligations upon us. An adverse outcome in an
infringement action could materially and adversely affect our financial condition, results of
operations and cash flows.
We may not be able to protect our intellectual property rights adequately.
Our ability to compete is affected by our ability to protect our intellectual property rights.
We rely on a combination of patents, trademarks, copyrights, trade secrets, confidentiality
procedures and non-disclosure and licensing arrangements to protect our intellectual property
rights. Despite these efforts, we cannot be certain that the steps we take to protect our
proprietary information will be adequate to prevent misappropriation of our technology, or that our
competitors will not independently develop technology that is substantially similar or superior to
our technology. More specifically, we cannot assure that our pending patent applications or any
future applications will be approved, or that any issued patents will provide us with competitive
advantages or will not be challenged by third parties. Nor can we assure that, if challenged, our
patents will be found to be valid or enforceable, or that the patents of others will not have an
adverse effect on our ability to do business. We may also become subject to or initiate
interference proceedings in the U.S. Patent and Trademark Office, which can demand significant
financial and management resources and could harm our financial results. Also, others may
independently develop similar products or processes, duplicate our products or processes or design
their products around any patents that may be issued to us.
Because our products typically have lengthy sales cycles, we may experience substantial delays
between incurring expenses related to research and development and the generation of revenues.
The time from initiation of design to volume production of new semiconductors often takes 18
months or longer. We first work with customers to achieve a design win, which may take nine months
or longer. Our customers then complete the design, testing and evaluation process and begin to ramp
up production, a period that may last an additional nine months or longer. As a result, a
significant period of time may elapse between our research and development efforts and our
realization of revenues, if any, from volume purchasing of our products by our customers.
We may not be able to increase production capacity to meet the present and future demand for our
products.
The semiconductor industry has been characterized by periodic limitations on production
capacity. From time to time, our production at external foundries has been limited by the foundries
because of their production constraints, superior revenue alternatives or desire for customer
diversification. Although we may be able to obtain the capacity necessary to meet present demand,
if we are unable to increase our production capacity to meet possible future demand, some of our
customers may seek other sources of supply or our future growth may be limited.
35
Table of Contents
The markets in which we participate are intensely competitive.
Certain of our target markets are intensely competitive. Our ability to compete successfully
in our target markets depends on the following factors:
| proper new product definition; | ||
| product quality, reliability and performance; | ||
| product features; | ||
| price; | ||
| timely delivery of products; | ||
| technical support and service; | ||
| design and introduction of new products; | ||
| market acceptance of our products and those of our customers; and | ||
| breadth of product line. |
In addition, our competitors or customers may offer new products based on new technologies,
industry standards or end-user or customer requirements, including products that have the potential
to replace our products or provide lower cost or higher performance alternatives to our products.
The introduction of new products by our competitors or customers could render our existing and
future products obsolete or unmarketable.
Our primary power semiconductor competitors include Fairchild Semiconductor, Fuji, Hitachi,
Infineon, International Rectifier, Microsemi, Mitsubishi, On Semiconductor, Powerex, Renesas
Technology, Semikron International, STMicroelectronics, Toshiba and Vishay Intertechnology. Our IC
products compete principally with those of Supertex, Matsushita, NEC and Silicon Labs. Our RF power
semiconductor competitors include RF Micro Devices. Many of our competitors have greater financial,
technical, marketing and management resources than we have. Some of these competitors may be able
to sell their products at prices below which it would be profitable for us to sell our products or
benefit from established customer relationships that provide them with a competitive advantage. We
cannot assure that we will be able to compete successfully in the future against existing or new
competitors or that our operating results will not be adversely affected by increased price
competition.
We rely on our distributors and sales representatives to sell many of our products.
Many of our products are sold to distributors or through sales representatives. Our
distributors and sales representatives could reduce or discontinue sales of our products. They may
not devote the resources necessary to sell our products in the volumes and within the time frames
that we expect. In addition, we depend upon the continued viability and financial resources of
these distributors and sales representatives, some of which are small organizations with limited
working capital. These distributors and sales representatives, in turn, depend substantially on
general economic conditions and conditions within the semiconductor industry. We believe that our
success will continue to depend upon these distributors and sales representatives. If any
significant distributor or sales representative experiences financial difficulties, or otherwise
becomes unable or unwilling to promote and sell our products, our business could be harmed. For
example, All American Semiconductor, Inc., one of our former distributors, filed for bankruptcy in
April 2007.
Our future success depends on the continued service of management and key engineering personnel
and our ability to identify, hire and retain additional personnel.
Our success depends upon our ability to attract and retain highly skilled technical,
managerial, marketing and finance personnel, and, to a significant extent, upon the efforts and
abilities of Nathan Zommer, Ph.D., our President and Chief Executive Officer, and other members of
senior management. The loss of the services of one or more of our senior management or other key
employees could adversely affect our business. We do not maintain key person life insurance on any
of our officers, employees or consultants. There is intense competition for qualified employees in
the semiconductor industry, particularly for highly skilled design, applications and test
engineers. We may not be able to continue to attract and retain engineers or other qualified
personnel necessary for the development of
36
Table of Contents
our business or to replace engineers or other qualified
individuals who could leave us at any time in the future. If we grow, we expect increased demands
on our resources, and growth would likely require the addition of new management and engineering
staff as well as the development of additional expertise by existing management employees. If we
lose the services of or fail to recruit key engineers or other technical and management personnel,
our business could be harmed.
Acquisitions and expansion place a significant strain on our resources, including our information systems and our employee base.
Presently, because of past acquisitions, we are operating a number of different information
systems that are not integrated. In part because of this, we use spreadsheets, which are prepared
by individuals rather than automated systems, in our accounting. In our accounting, we perform many
manual reconciliations and other manual steps, which result in a high risk of errors. Manual steps
also increase the possibility of control deficiencies and material weaknesses.
If we do not adequately manage and evolve our financial reporting and managerial systems and
processes, our ability to manage or grow our business may be harmed. Our ability to successfully
implement our goals and comply with regulations, including those adopted under the Sarbanes-Oxley
Act of 2002, requires an effective planning and management system and process. We will need to
continue to improve existing, and implement new, operational and financial systems, procedures and
controls to manage our business effectively in the future.
In improving our operational and financial systems, procedures and controls, we would expect
to periodically implement new software and other systems that will affect our internal operations
regionally or globally. The conversion process from one system to another is complex and could
require, among other things, that data from the existing system be made compatible with the
upgraded system. During any transition, we could experience errors, delays and other
inefficiencies, which could adversely affect our business. Any delay in the implementation of, or
disruption in the transition to, any new or enhanced systems, procedures or controls, could harm
our ability to forecast sales demand, manage our supply chain, achieve accuracy in the conversion
of electronic data and record and report financial and management information on a timely and
accurate basis. In addition, as we add additional functionality, new problems could arise that we
have not foreseen. Such problems could adversely impact our ability to do the following in a timely
manner: provide quotes; take customer orders; ship products; provide services and support to our
customers; bill and track our customers; fulfill contractual obligations; and otherwise run our
business. Failure to properly or adequately address these issues could result in the diversion of
managements attention and resources, impact our ability to manage our business and our results of
operations, cash flows and stock price could be negatively impacted.
Any future growth would also require us to successfully hire, train, motivate and manage new
employees. In addition, continued growth and the evolution of our business plan may require
significant additional management, technical and administrative resources. We may not be able to
effectively manage the growth or the evolution of our current business.
We depend on a limited number of suppliers for our substrates, most of whom we do not have long
term agreements with.
We purchase the bulk of our silicon substrates from a limited number of vendors, most of whom
we do not have long term supply agreements with. Any of these suppliers could reduce or terminate
our supply of silicon substrates at any time. Our reliance on a limited number of suppliers
involves several risks, including potential inability to obtain an adequate supply of silicon
substrates and reduced control over the price, timely delivery, reliability and quality of the
silicon substrates. We cannot assure that problems will not occur in the future with suppliers.
Costs related to product defects and errata may harm our results of operations and business. |
Costs associated with unexpected product defects and errata (deviations from published
specifications) due to, for example, unanticipated problems in our manufacturing processes, include
the costs of:
| writing off the value of inventory of defective products; | ||
| disposing of defective products that cannot be fixed; | ||
| recalling defective products that have been shipped to customers; | ||
| providing product replacements for, or modifications to, defective products; and/or | ||
| defending against litigation related to defective products. |
These costs could be substantial and may therefore increase our expenses and lower our gross
margin. In addition, our reputation with our customers or users of our products could be damaged as
a result of such product defects and errata, and the demand for our products could be reduced.
These factors could harm our financial results and the prospects for our business.
37
Table of Contents
We face the risk of financial exposure to product liability claims alleging that the use of
products that incorporate our semiconductors resulted in adverse effects.
Approximately 13.8% of our net revenues for the nine months ended December 31, 2009 were
derived from sales of products used in medical devices, such as defibrillators. Product liability
risks may exist even for those medical devices that have received regulatory approval for
commercial sale. We cannot be sure that the insurance that we maintain against product liability
will be adequate to cover our losses. Any defects in our semiconductors used in these devices, or
in any other product, could result in significant product liability costs to us.
We estimate tax liabilities, the final determination of which is subject to review by domestic and international taxation authorities.
We are subject to income taxes and other taxes in both the United States and the foreign
jurisdictions in which we currently operate or have historically operated. We are also subject to
review and audit by both domestic and foreign taxation authorities. The determination of our
worldwide provision for income taxes and current and deferred tax assets and liabilities requires
significant judgment and estimation. The provision for income taxes can be adversely affected by a
variety of factors, including but not limited to changes in tax laws, regulations and accounting
principles, including accounting for uncertain tax positions, or interpretation of those changes.
Significant judgment is required to determine the recognition and measurement attributes prescribed
in the authoritative guidance issued by FASB in connection with accounting for income taxes.
Although we believe our tax estimates are reasonable, the ultimate tax outcome may materially
differ from the tax amounts recorded in our consolidated financial statements and may materially
affect our income tax provision, net income or cash flows in the period or periods for which such
determination is made.
Our results of operations could vary as a result of the methods, estimates, and judgments that we use in applying our accounting policies.
The methods, estimates, and judgments that we use in applying our accounting policies have a
significant impact on our results of operations (see Critical Accounting Policies and Significant Management Estimates in Part I,
Item 2 of this Form 10-Q). Such methods, estimates, and judgments are, by their nature, subject to
substantial risks, uncertainties, and assumptions, and factors may arise over time that lead us to
change our methods, estimates, and judgments. Changes in those methods, estimates, and judgments
could significantly affect our results of operations.
We are exposed to various risks related to the regulatory environment.
We are subject to various risks related to: (1) new, different, inconsistent or even
conflicting laws, rules and regulations that may be enacted by legislative bodies and/or regulatory
agencies in the countries in which we operate; (2) disagreements or disputes between national or
regional regulatory agencies; and (3) the interpretation and application of laws, rules and
regulations. If we are found by a court or regulatory agency not to be in compliance with
applicable laws, rules or regulations, our business, financial condition and results of operations
could be materially and adversely affected.
In addition, approximately 13.8% of our net revenues for the nine months ended December 31,
2009 were derived from the sale of products included in medical devices that are subject to
extensive regulation by numerous governmental authorities in the United States and internationally,
including the U.S. Food and Drug Administration, or FDA. The FDA and certain foreign regulatory
authorities impose numerous requirements for medical device manufacturers to meet, including
adherence to Good Manufacturing Practices, or GMP, regulations and similar regulations in other
countries, which include testing, control and documentation requirements. Ongoing compliance with
GMP and other applicable regulatory requirements is monitored through periodic inspections by
federal and state agencies, including the FDA, and by comparable agencies in other countries. Our
failure to comply with applicable regulatory requirements could prevent our products from being
included in approved medical devices.
Our business could also be harmed by delays in receiving or the failure to receive required
approvals or clearances, the loss of previously obtained approvals or clearances or the failure to
comply with existing or future regulatory requirements.
We are subject to internal control evaluations and attestation requirements of Section 404 of the Sarbanes-Oxley Act.
Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, we must include in our Annual
Report on Form 10-K a report from management on the effectiveness of our internal controls over
financial reporting and an attestation by our independent registered public accounting firm to the
adequacy of managements assessment of our internal control. Ongoing compliance with these
requirements is complex, costly and time-consuming. If (1) we fail to maintain effective internal
control over financial reporting; (2) our management does not timely assess the adequacy of such
internal control; or (3) our independent registered public accounting firm does not timely attest
to the evaluation, we could be subject to regulatory sanctions and the publics perception of our
company may decline.
38
Table of Contents
If our long-lived assets become impaired, we may be required to record a significant charge to
earnings.
Under generally accepted accounting principles, we review our long-lived assets for impairment
when events or changes in circumstances indicate the carrying value may not be recoverable. Factors
that may be considered a change in circumstances indicating that the carrying value of our
long-lived assets may not be recoverable include a decline in stock price and market
capitalization, future cash flows and slower growth rates in our industry.
We invest in companies for strategic reasons and may not realize a return on our investments.
We make investments in companies to further our strategic objectives and support our key
business initiatives. Such investments include investments in equity securities of public companies
and investments in non-marketable equity securities of private companies, which range from
early-stage companies that are often still defining their strategic direction to more mature
companies whose products or technologies may directly support a product or initiative. The success
of these companies is dependent on product development, market acceptance, operational efficiency,
and other key business success factors. The private companies in which we invest may fail because
they may not be able to secure additional funding, obtain favorable investment terms for future
financings, or take advantage of liquidity events such as initial public offerings, mergers, and
private sales. If any of these private companies fail, we could lose all or part of our investment
in that company. If we determine that an other-than-temporary decline in the fair value exists for
the equity securities of the public and private companies in which we invest, we write down the
investment to its fair value and recognize the related write-down as an investment loss.
Furthermore, when the strategic objectives of an investment have been achieved, or if the
investment or business diverges from our strategic objectives, we may decide to dispose of the
investment even at a loss. Our investments in non-marketable equity securities of private companies
are not liquid, and we may not be able to dispose of these investments on favorable terms or at
all. The occurrence of any of these events could negatively affect our results of operations.
Our ability to access capital markets could be limited.
From time to time, we may need to access the capital markets to obtain long term financing.
Although we believe that we can continue to access the capital markets on acceptable terms and
conditions, our flexibility with regard to long term financing activity could be limited by our
existing capital structure, our credit ratings and the health of the semiconductor industry. In
addition, many of the factors that affect our ability to access the capital markets, such as the
liquidity of the overall capital markets and the current state of the economy, are outside of our
control. There can be no assurance that we will continue to have access to the capital markets on
favorable terms.
Geopolitical instability, war, terrorist attacks and terrorist threats, and government responses
thereto, may negatively affect all aspects of our operations, revenues, costs and stock prices.
Any such event may disrupt our operations or those of our customers or suppliers. Our markets
currently include South Korea, Taiwan and Israel, which are currently experiencing political
instability. Additionally, our principal external foundry is located in South Korea.
Business interruptions may damage our facilities or those of our suppliers.
Our operations and those of our suppliers are vulnerable to interruption by fire, earthquake
and other natural disasters, as well as power loss, telecommunications failure and other events
beyond our control. We do not have a detailed disaster recovery plan and do not have backup
generators. Our facilities in California are located near major earthquake faults and have
experienced earthquakes in the past. If any of these events occur, our ability to conduct our
operations could be seriously impaired, which could harm our business, financial condition and
results of operations and cash flows. We cannot be sure that the insurance we maintain against
general business interruptions will be adequate to cover all our losses.
We may be affected by environmental laws and regulations.
We are subject to a variety of laws, rules and regulations in the United States, England and
Germany related to the use, storage, handling, discharge and disposal of certain chemicals and
gases used in our manufacturing process. Any of those regulations could require us to acquire
expensive equipment or to incur substantial other expenses to comply with them. If we incur
substantial additional expenses, product costs could significantly increase. Failure to comply with
present or future environmental laws, rules and regulations could result in fines, suspension of
production or cessation of operations.
Nathan Zommer, Ph.D. owns a significant interest in our common stock.
Nathan Zommer, Ph.D., our President and Chief Executive Officer, beneficially owned or
controlled, as of January 29, 2010, approximately 22.4% of the outstanding shares of our common
stock. As a result, Dr. Zommer can exercise significant control over all matters requiring
stockholder approval, including the election of the board of directors. His holdings could result
in a delay of, or serve as a deterrent to, any change in control of IXYS, which may reduce the
market price of our common stock.
39
Table of Contents
Our stock price is volatile.
The market price of our common stock has fluctuated significantly to date. The future market
price of our common stock may also fluctuate significantly in the event of:
| variations in our actual or expected quarterly operating results; | ||
| announcements or introductions of new products; | ||
| technological innovations by our competitors or development setbacks by us; | ||
| conditions in the communications and semiconductor markets; | ||
| the commencement or adverse outcome of litigation; | ||
| changes in analysts estimates of our performance or changes in analysts forecasts regarding our industry, competitors or customers; | ||
| announcements of merger or acquisition transactions or a failure to achieve the expected benefits of an acquisition as rapidly or to the extent anticipated by financial analysts; | ||
| terrorist attack or war; | ||
| sales of our common stock by one or more members of management, including Nathan Zommer, Ph.D., our President and Chief Executive Officer; or | ||
| general economic and market conditions. |
In addition, the stock market in recent years has experienced extreme price and volume
fluctuations that have affected the market prices of many high technology companies, including
semiconductor companies. These fluctuations have often been unrelated or disproportionate to the
operating performance of companies in our industry, and could harm the market price of our common
stock.
The anti-takeover provisions of our certificate of incorporation and of the Delaware General
Corporation Law may delay, defer or prevent a change of control.
Our board of directors has the authority to issue up to 5,000,000 shares of preferred stock
and to determine the price, rights, preferences, privileges and restrictions, including voting
rights, of those shares without any further vote or action by our stockholders. The rights of the
holders of common stock will be subject to, and may be harmed by, the rights of the holders of any
shares of preferred stock that may be issued in the future. The issuance of preferred stock may
delay, defer or prevent a change in control because the terms of any issued preferred stock could
potentially prohibit our consummation of any merger, reorganization, sale of substantially all of
our assets, liquidation or other extraordinary corporate transaction, without the approval of the
holders of the outstanding shares of preferred stock. In addition, the issuance of preferred stock
could have a dilutive effect on our stockholders.
Our stockholders must give substantial advance notice prior to the relevant meeting to
nominate a candidate for director or present a proposal to our stockholders at a meeting. These
written notice requirements could inhibit a takeover by delaying stockholder action. The Delaware
anti-takeover law restricts business combinations with some stockholders once the stockholder
acquires 15% or more of our common stock. The Delaware statute makes it more difficult for us to be
acquired without the consent of our board of directors and management.
40
Table of Contents
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Not applicable.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
Not applicable.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
Not applicable.
ITEM 5. OTHER INFORMATION
Not applicable.
ITEM 6. EXHIBITS
See the Index to Exhibits, which is incorporated by reference herein.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned thereunto duly authorized.
IXYS CORPORATION | ||||
By: /s/ Uzi Sasson
|
||||
Chief Financial Officer | ||||
(Principal Financial Officer) |
Date: February 5, 2010
41
Table of Contents
EXHIBIT INDEX
Exhibit | ||
No. | Description | |
2.1
|
Agreement and Plan of Merger by and among IXYS Corporation, Zanzibar Acquisition, Inc. and Zilog, Inc. dated as of December 5, 2009 (filed on December 7, 2009 as Exhibit 2.1 to the Current Report on Form 8-K (No. 000-26124) and incorporated herein by reference). | |
10.1
|
Credit Agreement dated as of November 13, 2009 by and between Bank of the West and IXYS Corporation. | |
31.1
|
Certificate of Chief Executive Officer required under Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2
|
Certificate of Chief Financial Officer required under Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1
|
Certification required under Section 906 of the Sarbanes-Oxley Act of 2002. (1) |
(1) | This exhibit is furnished and shall not be deemed filed for purposes of Section 18 of the Securities and Exchange Act of 1933, as amended (the Exchange Act), or incorporated by reference in any filing under the Securities and Exchange Act of 1993, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. |